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S3
UV stimulate the production of granzyme B in keratinocytes:
implication in photoaging
C. Jean, A. Blanc, H. Hernandez-Pigeon, M. Charveron, G. Laurent. INSERM U563, CPTP,
Toulouse-Purpan; IRPF Dermo-Cosme´tique, Toulouse, France
Granzyme B (GrB) is a serine protease mainly distributed in immune cells. However, we
have previously shown that genotoxic stress or pro-inflammatory cytokines were able to induce
the production of catalytically active GrB in non-lymphoid cells. Here, we have evaluated GrB
expression and function in UV-treated keratinocytes. UVB and UVA induced GrB synthesis at the
transcriptional level in keratinocytes (HaCaT cell line and primary human keratinocytes) by a
redox- and p38MAPK-dependent mechanism. GrB was secreted under its active form in the
extracellular milieu, where it has been shown to degrade fibronectin, laminin, and vitronectin
without any effect on collagen. The degradation of these major components of the extracellular
matrix (ECM) was responsible for keratinocyte detachment and anoikis-type cell death. The
inhibition of this mechanism (depletion of GrB by oligonucleotide antisense) protected cell
against UV toxicity and unmasked previously not described but potent pro-migratory UVA effect.
Altogether, we propose a model in which solar irradiation induced a heterotopic production of
GrB responsible for major ECM alterations that could contribute to photoaging. Moreover, this
mechanism appears to play an important role in eliminating irradiated cell by detachment, and
therefore could also contribute to the loss of keratinocyte mass in photoaged skin.
\S4
PET scan identification of brain area activation after pruritic
stimulation
L. Bergeret1, D. Black2, J. Theunis2, P. Celsis1. 1Inserm U825, Hoˆpital Purpan, Toulouse, France;
2Centre de Recherche sur la Peau—IRPF, Toulouse, France
The decrease in the quality of life of patients suffering from chronic pruritus is a recognized
fact; yet, the physiopathological mechanisms of this unpleasant and invalidating sensation remain
largely unknown. With regard to this, few studies have aimed at showing the brain networks
involved in the pruritic or itch sensation. However, recent progress in functional neuroimaging
should allow a better understanding of the central mechanisms involved, in distinguishing them
from those of pain, notably in patients suffering from chronic disease (for example, atopic
dermatitis). We were interested in studying brain activation during itch sensation using H2O
15
positron emission tomography, and its central modulation by a high attention task (visual Stroop).
Itch was induced in a group of 14 normal healthy male volunteers aged 18–35 years, using
histamine applied iontophoretically on the forearm, with physiological saline used as control.
These two application modes were repeated using the visual Stroop. The image capture sequence
was started 2.5 minutes after iontophoretic application, with a total of three images per
application mode. At the end of this sequence, the volunteer was asked to rate itch intensity using
a 10-cm visual analog scale. The contrast between histamine and saline modes showed increased
activation in the sensory (parietal) and frontal areas, despite a relatively low-rated itch sensation
(1.5 cm). These results are in agreement with those of the literature. Further analyses are in
progress to ascertain the central modulation effect (visual Stroop).
S5
CD8þ T lymphocytes in the initiation of atopic dermatitis
lesions
A. Hennino1,2, F. Giordano-Labadie3, C. Jean-Decoster4, A.-M. Schmitt4, J.-F. Nicolas1,2,5.
1INSERM, U851; 2University of Lyon 1, Lyon, France; 3Department of Dermatology, Hoˆpital
Purpan, CH Toulouse, France; 4Centre for Skin Research—IRPF, Toulouse, France; 5HCL, Clinical
Immunology and Allergy, CH Lyon Sud, Pierre Be´nite, France
Eczema in atopic dermatitis (AD) is a cutaneous hypersensitivity syndrome reaction involving
T lymphocytes (TLs) specific to respiratory allergens in contact with the skin. Our recent study
using the preclinical AD model in mice with induction by application of an allergenic protein
extract from the house dust mite (Dermatophagoides farinae, Der f) shows that the effector TL
responsible for eczema are IFN-g-producing CD8þ TLs (Tc1) that infiltrate the skin and induce
apoptosis of the keratinocytes. In addition, activation of CD8þ TL is under the control of
regulator/tolerogen CD4þ TL (Treg cells). To verify these results in humans, we carried out a two-
centre clinical study in 14 adults affected by AD using the atopy patch test (APT) model, which
reproduces AD in miniature after application of the allergic protein to the skin. All patients had a
positive APT for Der f or Dermatophagoides pteronyssinus. The subjects were randomized into
three groups, with patch tests applied for different periods: 9, 24, and 48 hours. Two patch
biopsies were performed on each patient, namely petroleum jelly (negative control) and acarian
protein. The biopsies were embedded in paraffin and immunohistochemical staining was carried
out (anti-CD8, anti-CD3, anti-Foxp3, anti-granzyme B, and anti-CD25). The results show that
CD8þ TLs are recruited in the epidermis immediately after the application of the Ag, before the
appearance of skin inflammation and a clinically positive ATP. These CD8þ TLs are cytotoxic
because they express granzyme B. This phase of cytotoxic CD8þ TL recruitment is followed by
recruitment of the Foxp3 regulator TL, which probably plays an important role in the resolution of
the inflammatory reaction. These results confirm those obtained in the experimental AD model in
mice and suggest that CD8þ TLs initiate the eczema lesions in AD.
O1
Impact of the TLR2 and TLR4 polymorphisms in atopic
dermatitis
F Boralevi1,2, C Ged3, T Hubiche2, H Martin1, A Taı¨eb2,3, C Davrinche1. 1Inserm U563, Toulouse
; 2Service de Dermatologie and 3Inserm U876, Bordeaux, France
Staphylococcus aureus exotoxins may enhance skin inflammation in atopic dermatitis (AD)
through activation of the innate immune system. Our objectives were (1) to study Toll-like
receptor (TLR)2 and TLR4 as AD susceptibility genes in France and (2) to compare staphylococcal
enterotoxin A (SEA)- and staphylococcal enterotoxin B (SEB)-induced cytokine responses in
monocytes isolated from TLR2R/Q and TLR4D/G variants. A total of 145 AD patients and 52
controls were enrolled in the polymorphism study, and subsequently grouped into TLR2wt-
TLR4wt, TLR2R/Q-TLR4wt, TLR2wt-TLR4D/G, and TLR2R/Q-TLR4D/G groups. CD14þ monocytes
were isolated, cultured, and stimulated with 10 ng ml1 of highly purified SEA, SEB, and
lipopolysaccharide (LPS). Cytokines and chemokines, that is tumor necrosis factor-a (TNF-a) and
IP-10, were measured in the supernatant. The allelic frequencies of the TLR2 D753G and TLR4
D299G polymorphisms were 0.02 and 0.066, respectively, in the AD group, and 0.0 and 0.049,
respectively, in controls. SEB or SEA stimulation increased significantly TNF-a, IP-10, and IL-6
production in AD and controls. LPS enhanced the production of IP-10 only in controls. SEB-
induced TNF-a production decreased significantly in TLR2R/Q and TLR4D/G variants. In controls,
LPS-induced IP-10 secretion decreased significantly in TLR4D/G variants. Monocytes from AD are
functionally defective in their capacity to produce TNF-a and IP-10—a chemokine that may play
an important role by attracting activated TH1 cells. This further sustain that a better knowledge on
interaction of SEB with TLR2 and TLR4 could provide new clues on AD pathogenic mechanisms.
O2
Critical role of TLR2 and TLR4 in autoantibody production and
glomerulonephritis in lpr mutation-induced mouse lupus
A. Lartigue1, A. Franc¸ois2, S. Jacquot1, C. Arnoult1, F. Tron1, D. Gilbert1, P. Musette1,3. 1INSERM,
U905, Rouen; University of Rouen, IFRMP, Institute for Biomedical Research; 2Laboratoire
d’Anatomie-Pathologique, Charles Nicolle University Hospital, Rouen; 3Service de Dermatolo-
gie, Charles Nicolle University Hospital, Rouen, France
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the
production of pathogenic autoantibodies directed against nuclear antigens and the deposit of
immune complex in damaged organs. Environmental factors, in particular microbial pathogens,
have been believed to play a role in the onset of the disease. The recognition of pathogen-
associated molecular patterns is mediated by Toll-like receptors (TLRs) and in particular by TLR2
and TLR4, which bind components from Gram-positive and Gram-negative bacteria, respectively,
and we sought to determine the role of these TLRs in SLE by creating C57BL/6lpr/lpr-TLR2/ and
C57BL/6lpr/lpr-TLR4/ mice and analyzing their phenotype. TLR2- and TLR4-deficient mice
developed a less-severe clinical disease with few immunological alterations. Indeed, assessment
of the renal disease shows that glomerular IgG deposits were less intense in these TLR-deficient
lupus mice and were associated with a diminution of mesangial cell proliferation. The production
of autoantibodies presented significant differences compared with C57BL/6lpr/lpr mice. Indeed,
anti-dsDNA and anti-cardiolipin autoantibodies were decreased in TLR2- and TLR4-deficient
mice, whereas the response against nucleosome remained unaffected in TLR4/ mice,
suggesting the role of these TLR in the production of antibodies directed against T-cell
independent antigens. Moreover, B-cell phenotypes and cytokine profiles presented abnormal-
ities, which suggested an important role of TLR4 in the sustained activation of marginal zone B
(MZB) cells and autoantibody production observed in SLE.
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O3
Development of specific biological tests for B- and T-cell
immune response against type VII collagen: tools for genetic
therapy in RDEB patients
V. Pendaries1, G. Albe´rola1, M. Titeux1, C. Leroux2, J. Mejia1, A. De´cha1, C. Prost2, and A.
Hovnanian1,3. 1Inserm, U563, Toulouse, France; 2Avicenne Hospital, Bobigny, France; 3CHU
Purpan, Toulouse, France
Dystrophic epidermolysis bullosa (DEB) is an inherited disorder caused by loss-of-function
mutations in the gene encoding for type VII collagen, the component of anchoring fibrils. In
addition to DEB, epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease
displaying circulating autoantibodies against type VII collagen. To evaluate the immunologic risk
in recessive DEB patients during gene therapies aiming at restoring type VII collagen expression,
we have developed ELISA and ELISPOT assays using the full-length type VII collagen molecule.
The ELISA assay detected type VII collagen circulating antibodies with a high specificity (95%)
and sensitivity (65%) within a cohort of 45 untreated EBA patients. The ELISPOT assay detected a
Th1 immune response against type VII collagen, which correlated with disease activity. We
subsequently tested four patients suffering from RDEB. The ELISA assay was positive for anti-type
VII collagen circulating antibodies in one of the two patients who did not express detectable type
VII collagen. The ELISPOT score was negative in the two patients who expressed low levels or a
truncated form of type VII collagen. Conversely, a positive Th1 immune response was observed in
two RDEB patients who expressed no type VII collagen. HLA genotyping of these patients is in
progress. The immunologic tests for the B- and T-cell immune response to type VII collagen that
we have developed will be useful to select candidates for clinical trials of gene therapy for RDEB.
They will also be essential to the immunological follow-up of treated RDEB patients during these
trials.
O4
Impact of tacrolimus on cutaneous neurogenic inflammation
U Pereira, J.-P. Pennec, G Dorange, L Misery. EA 4326 Nerves Factors and Tissular Structuration,
University of Western Britany, Brest, France
The calcineurin inhibitor tacrolimus (Tac) or FK506 is an antifungal natural macrolide and
used as an immunosuppressant and in the treatment of atopic dermatitis. The application is often
followed by transient adverse sensations such as burning and itching at the beginning of topical
therapy, whereas tacrolimus has a very interesting anti-pruritic effect later, suggesting a capsaicin-
like mechanism. To understand the underlying mechanism of these effects, we examined the
impact of FK506 on an in vitro model of cutaneous neurogenic inflammation (CNI). This model is
based on an enzyme immunoassay (EIA) of SP (marker of CNI) in a porcine co-culture (very close
to human response) of dorsal root ganglion neurons and keratinocytes. After direct exposition of
different concentrations of tacrolimus, we noted an immediate increase in SP basal release.
However, the use of a medium without calcium or an antagonist of calcium channel such as
ruthenium red was able to inhibit this release. The pretreatment (24 or 72 hours) of the co-culture
by Tac was sufficient to reduce an artificial inflammation (miming a CNI) induced by capsaicin.
Furthermore, electrophysiological study shows an important inhibition of calcium channels after
these pretreatment. These results suggest that application of tacrolimus may lead to neuropeptide
release by a calcium influx and cause a neuropeptide depletion of nerve fibers, which explains
the initial inflammatory effects (pain, itching, and burning) and secondly, the soothing effect,
through a no immunological mechanism.
O5
CD40 stimulation and autoimmunity promotes Breg cell
development
J.-D. Bouaziz, K. Yanaba, T.-F. Tedder. Service d’immunologie, Duke University Medical Center,
Durham, North Carolina, USA; Unite´ INSERM 841, Hospital Henri Mondor, Cre´teil, France
We have discovered regulatory B (Breg) cells that inhibit contact dermatitis. These cells have
a CD1dhighCD5þ phenotype and produce high levels of IL-10. The aim of our study was to
evaluate which stimuli trigger IL-10 production by Breg cells and determine Breg cell frequencies
in various autoimmune disease models. Purified Breg cells were stimulated in vitro. Intracellular
cytokine staining was used to quantify IL-10. The frequencies and numbers of splenic Breg cells
were quantified in different transgenic mice and compared with wild-type mice: mice with a
hypersensitivity of their CD40 signaling pathway (CD40L/BTg, CD22/, and CD40L/BTg CD22/
) and autoimmune mice (lupus models: NZB/W F1 and MRL/lpr mice; diabetes model: NOD
mice). LPS stimulation induced IL-10 in 1–2% of wild-type B cells. Anti-CD40 stimulation and
anti-CD40þ LPS increased IL-10 production by 2.5 and 6.5 times, respectively. Overall 50% of
purified CD1dhighCD5þ B cells produced IL-10, whereas other B cells did not produce IL-10. Breg
cell frequencies were 1.9, 5.3, and 14.5 times higher in CD40L/BTg, CD22/, and CD40L/BTg
CD22/ mice, respectively (Po0.01), suggesting the contribution of CD40 signaling in Breg cell
development in vivo. Breg cell frequencies of 3.5, 2.6, and 4.9 times increased in NZB/W F1,
MRL/lpr, and NOD mice, respectively (Po0.01), which suggests Breg cell expansion during
autoimmunity. CD40 signaling pathway is important for Breg development. Moreover, Breg cell
expansion during autoimmunity suggests their role as negative regulators of immune response as a
mechanism of tolerance induction. CD40 stimulation of Breg cells in vivo may be a new
therapeutic target for autoimmune disease treatment.
O6
Protein GRA5 from Toxoplasma gondii triggered dendritic cells
migration in vitro and in vivo
F. Persat1, M.-F. Cesbron-Delauw4, D. Ficheux3, E. Collomb1, N. Bendridi1, K. Musset4, S. Picot2,
J. Diana1, C. Vincent1. 1EA 4169, 2EA 3170, 3IFR 128 and 4CNRS UMR5163, University of Lyon I,
Lyon, France
Toxoplasma gondii attracts immature dendritic cells (DCs) and, after infection controls the
immune response of the host. It triggers DC migration without maturation, modifies DC apoptosis,
and controls T lymphocytes response. We showed that migration required a soluble factor
originating from parasite’s dense granules. This factor induces a shift between CCR6 and CCR7,
inactivates the E-cadherin and induces the synthesis of matrix metalloproteinases. CD83, CD86,
and HLA-DR remain unmodified. Using knockout parasites, we identified the corresponding
gene. A set of synthetic peptides was produced and then the active site identified. Application of
this peptide at concentration o1 mg ml1 on human skin explants induces depletion of
Langerhans cells within 48 hours. In vivo, on the mouse ear epidermis, the peptide induces
depletion in 5 hours and part of the cells is recovered in draining lymph nodes. The peptide was
used in a model of contact hypersensitivity on mouse. Peptide was applied on skin of the animal,
5 hours later the same region was painted with DNFB. After 5 days, DNFB was applied on the ear
and ear thickness followed for 5 days. The inflammatory reaction was lowered in mice treated
with peptide compared with those treated with vehicle.
O7
Implication of oxidative stress and MAPKs in phenotypic
activation of dendritic cells induced by contact sensitizers
C. Migdal1, L. Foggia1, S. Trompezinski2, A. Rossary3, J.-P. Steghens3, M. Tailhardat4, P.
Courtellemont4, M. Haftek1, M. Serres1. 1EA41-69, University Claude Bernard Lyon 1, Pavillon R,
Hospital E. Herriot, Lyon, France; 2DIPTA, Aix en Provence, France; 3EA30-90 UCBL1,
Fe´de´ration de Biochimie, Hospital E. Herriot, Lyon, France; 4LVMH Recherche, Saint Jean de
Braye, France
Although the maturation of dendritic cells (DCs) induced by sensitizers is well characterized
(phenotypic modifications, and cytokines production), earlier events involved in this process
required to be more specified. The aim of this study is to determine the crosstalk between kinase
activation and oxidative stress induced by contact allergens, in correlation with DC activation. To
address this purpose, thimerosal, other mercury compounds, and well-known allergens (DNCB,
NiSO4) were tested on DCs derived from monocytes (mono-DCs) and on a human monocytic cell
line (U937). The implication of p38 mitogen-activated protein kinase (MAPK) and Erk1/2
pathways was assessed by flow cytometry and a new sensitive method for detecting in situ protein
phosphorylation (Face method, Active motif). Several specific fluoroprobes were used to detect
reactive oxygen species (ROS) generation and glutathione (GSH) measured also by HPLC-MS. A
crosstalk between ROS, MAPK activation, and DC phenotypic activation (characterized by an
overexpression of selected surface activation markers CD86 and CD54) was shown using
antioxidants (N-acetyl-cysteine, GSH). These studies will enable manipulation of DCs in
inflammatory diseases and their use in cancer vaccinology.
O8
Epigenetic silencing of elastic fiber-related genes in cutis laxa
R. Debret1, S. Claus1, V. Ce´nizo2, A. Me´garbane´3, O. Damour1, P. Sommer1. 1Institut de Biologie
et Chimie des Prote´ines, CNRS UMR5086, Lyon, France; 2BASF-BCS, Lyon, France; 3Unite´ de
Ge´ne´tique Me´dicale, University Saint Joseph, Beirut, Lebanon
Congenital cutis laxa is characterized by a loose skin giving the patients a prematurely aged
appearance. We have reported the case of an 8-year-old boy for whom we identified an
autosomal-recessive mutation (c.649T-C; p.C217R) within the fibulin-5 gene, a protein
necessary for a correct elastic fiber assembly. Dermal fibroblasts from the patient were used to
establish a skin equivalent model showing a poor dermal matrix as well as an abnormal dermo-
epidermis junction. Cutis laxa fibroblasts grown as monolayers displayed a dramatic decrease in
the expression of several genes coding for elastic fiber partners. Among these genes, the lysyl
oxidase-like 1, a key enzyme for elastin crosslinks, was affected in a manner similar to normal
aging. We showed that a region in the proximal part of the lysyl oxidase-like 1 promoter, required
for optimum promoter activity, was silenced by de novo methylated cytosines. Using an inhibitor
of DNA-methyltranseferases, we allowed the rescue of lysyl oxidase-like 1 expression in cutis
laxa fibroblasts. In the same conditions, expression of the elastin gene also reached normal
values. In conclusion, our data show that the fibulin-5 mutation in cutis laxa cells is accompanied
by an epigenetic silencing of elastic fiber-related genes through a DNA-methyltransferase-
dependent mechanism.
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O9
Implication of lysyl oxidase in epidermal homeostasis
G. Le Provost1, V. Cenizo2, R. Debret1, C. Bouez1, O. Damour1, V. Andre´2, P. Sommer1. 1Institut
de Biologie et de Chimie des Prote´ines. Lyon, France and 2BASF Beauty Care Solutions, Lyon,
France
Lysyl oxidase (LOX) is an extracellular enzyme that catalyzes the cross-linking of fibrillar
collagens and elastin in connective tissues. LOX has also been reported to play a key role in tumor
progression, but its functions remain unclear. Both up- and downregulations of LOX have been
described in several types of cancers, suggesting a dual role for LOX as a pro-tumoral as well as an
anti-tumoral entity. We previously reported LOX expression in normal human epidermis,
restricted to suprabasal keratinocytes. Furthermore, LOX was not expressed in tumoral foci of
basal and squamous cell carcinomas. Inhibition of LOX enzymatic activity in a skin equivalent
model perturbed both basement membrane formation and expression patterns of some terminal
differentiation markers, yet preserving the whole tissue organization. Nevertheless, extinction of
LOX expression in HaCaT cell line induced an invading phenotype, underlining the importance
of LOX protein in the maintenance of epidermal integrity. Performing a screening of potential
inducers, we found that an Ephedra plant extract was able to induce LOX gene expression in
keratinocyte monolayers. At the same time, an increase in the expression of some early
differentiation markers was observed. Application of the Ephedra extract in a skin equivalent
model increased thickness and improved global quality of the epidermis. Taken together, these
results suggest that a subtle regulation of LOX expression is crucial for homeostasis in normal
human epidermis.
O10
cH2AX, a marker of chronic and acute genotoxicity in human
skin and keratinocytes
L. Barnes1,2, A. Bernois2, M. Juan2, E. Noblesse2, M. Dumas2, S. Schnebert2, B. Guillot1, J.-P.
Mole`s1. 1Laboratoire de Dermatologie Mole´culaire, Montpellier, France; 2LVMH Recherche,
Saint Jean de Braye, France
Among the actors for DNA damage repair, the phosphorylated form of the H2AX histone is
known to have a pivotal role. However, its expression and its role remain unknown in
keratinocytes and human skin. We attempted to describe the expression profile of this marker in
normal human epidermis. The gH2AX foci were infrequently detected and mainly concentrated
in the basal layer, but some changes could be observed according to the age of the donor, the
chronic exposure to solar radiation, and the anatomic origin of the biopsy. Also, the detection of
cyclobutane pyrimidine dimers (CPD) correlated the variations of the gH2AX expression as an
accumulation of DNA photo-injuries in the basal layer was observed. We then investigated the
role of gH2AX in keratinocytes and in reconstructed epidermis when exposed to different doses of
acute UVB irradiations. We first observed that gH2AX expression was stimulated by UV
irradiations. In addition, according to its level of expression, two types of response after DNA
damage were defined, namely one triggering cells toward apoptosis and the other blocking cell
cycle for DNA repair. This checkpoint was independent of p53 activity. The high concentration of
histone proteins in cells makes this marker fairly easy to detect. These results highlight the
potential of the gH2AX as a marker in skin to study acute and chronic genotoxic stresses. A better
understanding of the phosphorylation of the H2AX histone could further let one to know how skin
protects itself against genotoxic agents at short or long timescales.
O11
Hair follicle RANK-ligand regulates epithelial growth through
Bcl-3
V. Duheron, L. Amoasi, M. Decossas, C.-G. Mueller. Laboratoire d’immunologie et chimie
the´rapeutiques, CNRS UPR 9021, IBMC, Strasbourg, France
The hair follicle is receiving increased attention for its renewal capacity and source of readily
accessible stem cells. It regulates the local immune and epidermal homeostasis and is source of
tumor cells. RANK-ligand, a tumor necrosis factor family member, is expressed by osteoblasts and
is required for formation of osteoclasts, specialized bone-absorbing macrophages. In view of
certain similarities between bone and skin, and because RANK-ligand is involved in mammary
gland development, we investigated whether RANK-ligand and its receptor RANK play a role in
hair follicle formation and epithelial homeostasis of the mouse skin. We found that RANK is
expressed at low levels in epithelial cells but RANK-ligand is strongly expressed in growing hair
follicles. Mice deficient in RANK-ligand are unable to enter the hair follicle anagen (growth)
phase and display reduced epidermal thickness. On the other hand, mice overproducing RANK-
ligand in the hair follicle show epidermal hyperplasia, indicating a requirement for RANK-ligand
for epithelial growth. To understand the signaling pathway triggered by RANK, we performed
immunolabeling and western blot analyses, and found that RANK induces nuclear translocation
of Bcl-3. Bcl-3 is a member of the NF-kB inhibitor family, but is capable of promoting gene
transcription when bound to p50 or p52 homodimers. As cylindromas show Bcl-3 nuclear
translocation, it is possible that RANK-ligand is implicated in the growth of these tumors.
O12
Characterization of bipotential epidermal progenitors derived
from human sebaceous gland: contrasting roles of b-catenin and
c-Myc
C. Lo Celso, M.-A. Berta, K.-M. Braun, M. Frye, S. Lyle, C.-C. Zouboulis and F.-M. Watt.
Cambridge Research Institute, Cancer Research, UK
Human epidermis can be reconstituted in culture for studies on stem cell renewal and
terminal differentiation into interfollicular epidermis (IFE). However, there are currently no
in vitro models of selection between alternative epidermal lineages. We have found that SZ95
cells derived from human sebaceous gland (SG) have bipotential differentiation capacity in vitro
and in vivo, as they can give rise to both the IFE and SG lineages. Activation of Myc stimulates
SZ95 sebocyte differentiation, whereas overexpression of b-catenin stimulates IFE differentiation,
characterized by the expression of the epidermal markers involucrin and cornifin. The different
effects of Myc and b-catenin on lineage selection were also examined in vivo, using double
transgenic mice. Simultaneous activation of Myc and b-catenin revealed mutual antagonism:
activation of Myc blocked b-catenin-mediated induction of ectopic hair follicle formation and
overexpression of b-catenin reduced SG differentiation. Our studies highlight the importance of
Myc as a regulator of sebocyte differentiation and provide evidence for a bipotential epidermal
stem cell population in an in vitro model of human epidermal lineage selection.
O13
Constitutive expression of MC1R in HaCaT keratinocytes
inhibits basal and UVB-induced TNF-a production
G. Garcin, L. Le Gallic, P.-E. Stoebner, A. Guezennec, J. Guesnet, T. Lavabre-Bertrand, J.
Martinez, L. Meunier. CNRS, UMR 5247, University of Montpellier I, France; YSL R&D Neuilly
sur Seine, France
a-Melanocyte-stimulating hormone (a-MSH) binds to melanocortin-1 receptor (MC1R) on
melanocytes to stimulate pigmentation and modulate various cutaneous inflammatory responses.
MC1R expression is not restricted to melanocytic cells and may be induced in keratinocytes after
UV exposure. We hypothesized that MC1R signaling in keratinocytes, where in basal conditions
is barely expressed, may modulate mediators of inflammation, such as NF-kB and tumor necrosis
factor-a (TNF-a). Therefore, we generated HaCaT cells that stably express human MC1R or the
Arg151Cys (R151C) non-functional variant. We show that (1) constitutive MC1R activity results in
elevated intracellular cAMP levels, reduced NF-kB activity, and decreased TNF-a transcription;
(2) binding of a-MSH to MC1R and the subsequent increase in cAMP production do not inhibit
TNFa-mediated NF-kB activation; and (3) MC1R signaling is sufficient to strongly inhibit UVB-
induced TNF-a expression and this inhibitory effect is further enhanced by a-MSH stimulation.
Our findings suggest that constitutive activity of the G-protein-coupled MC1R in keratinocytes
may contribute to the modulation of inflammatory events and immune response induced by
UV light.
O14
HIF1 transcription factor regulates laminin-332 expression and
keratinocyte migration
I. Bourget1,2, G. Fitsialos1,2, S. Augier1,2, A. Ginouve`s3, R. Rezzonico1,2, T. Odorisio4, F.
Cianfarani4, T. Virolle1,2, J. Pouysse´gur3, G. Meneguzzi1,2, E. Berra3,5, G. Ponzio1,2, R. Busca`1,2.
1INSERM U634; 2University of Nice Sophia Antipolis; 3CNRS UMR 6543, Nice, France;
4Laboratory of Molecular and Cellular Biology, IDI-IRCCS, Roma, Italy; 5CICbioGUNE, Derio,
Spain
Epidermal wound repair is a complex process involving a finely orchestrated regulation of
crucial cell functions (proliferation, adhesion, and migration). Using an in vitro model that
recapitulates the central aspects of epidermal wound healing, we show that the transcription
factor hypoxia-inducible factor 1 (HIF1) is strongly stimulated in keratinocyte cultures that have
subjected to mechanical injury. Signals generated by scratch wounding stabilize the HIF1a
protein, which requires activation of the PI3K pathway independent of the oxygen availability.
We further show that upregulation of HIF1a plays an essential role in keratinocyte migration
during the in vitro healing process, as HIF1a inhibition dramatically delays wound closure. In this
context, we show that HIF1 controls the expression of laminin-332, one of the major epithelial
cell adhesion ligands involved in cell migration and invasion. Indeed, HIFa silencing abrogates
the injury-induced laminin-332 expression, and we provide evidence that HIF1 directly regulates
the promoter activity of the laminin a3 chain. Our results suggest that HIF1 contributes to
keratinocyte migration and thus to the re-epithelialization process by regulating laminin-332.
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O15
Identification of transcription factors overexpressed in granular
keratinocytes by a large-scale multitechnique approach
N. Mattiuzzo, E. Toulza, G. Serre, M. Guerrin. UMR5165, CNRS-University of Toulouse III,
France
The identification of transcription factors expressed in granular keratinocytes is required to
elucidate the differentiation program, leading to the formation of the stratum corneum and the
establishment of the barrier function. Using large-scale techniques (microarrays, granular
keratinocytes ESTs libraries and bioinformatics), we first searched for genes differentially
expressed between granular keratinocytes and basal layer. Among 363 candidates, 181 were
detected in the epidermis and further validated by quantitative real-time PCR and sequencing,
with 55 genes upregulated in granular keratinocytes, a new expression site for most of them. A
total of 84 of the detected genes encoded transcription factors, among which 18 were
overexpressed and 17 underexpressed in granular keratinocytes relative to basal layer.
Upregulated transcription factor coding genes included FOXL1, a potential repressor of heparan
sulfate proteoglycans synthesis; GATA4, whose paralogue GATA3 is required for barrier function
establishment; and HOPX, a marker of lens fiber terminal differentiation. In the future, the
identification of their target genes will shed new light on the regulatory cascades responsible for
granular keratinocytes differentiation and barrier function of the epidermis.
O16
Identification of RUNX1 gene targets in human differentiated
keratinocytes
M. Molina1, S. Tendil2, X. Gidrol2, J. Lamartine1. 1CNRS UMR5534, University Lyon I,
Villeurbanne, France; 2CEA, Institut de Radiobiologie Cellulaire et Mole´culaire, Laboratoire
d’exploration Fonctionnelle des Ge´nomes, Evry, France
The transcription factor RUNX1 is expressed in the granular layer of human epidermis where
it might play a role in the control of keratinocytes differentiation. To identify the gene targets of
RUNX1 in the granular compartment, we used a bioinformatics approach to look for conserved
RUNX1 binding sequences in the promoter regions of 50 genes expressed in the granular layer.
Among these, 20 candidate target genes were selected comprising the genes coding for loricrin,
keratin 1, or transglutaminase 1. The expression of these genes was found to be modified in
differentiated keratinocytes after silencing of RUNX1 by RNA interference. The in vivo binding of
RUNX1 on these promoters was confirmed by chromatin immunoprecipitation in cultured
keratinocytes. We also started a global search of RUNX1 targets: the immunoprecipitated
chromatin was hybridized on an oligonucleotide microarray representing the promoter sequences
of 17,000 human genes (Agilent Technologies, Santa Clara, CA). The data from this ChIP chip
approach (still being analyzed) will lead to the identification of numerous new targets and
therefore should permit to precise the role of RUNX1 in the granular layer of human epidermis.
O17
Persistence of tight junction-like structures in the stratum
corneum compactum of human epidermis
S. Callejon, Y. Sandjeu, M. Haftek. University of Lyon 1, CNRS, Lyon, France
The presence and possible functions of tight junctions (TJ) in normal human epidermis is the
subject of recent discussion. Detection of several proteins typical of TJ in the epidermal
keratinocytes remains in conflict with freeze fracture studies that fail to show the typical
junctional strips characteristic of the functional structures. We studied the ultrastructure of the
human epidermis in search of hints indicating the presence of TJ between the keratinocytes.
Mouse jejunal epithelium served as the control for structural and immunocytochemical
investigations. Standard electron microscopy biopsies embedded in Epon were compared with
the low temperature-embedded samples in acrylic resins. Antibodies to claudin-1 and occludin
were employed for the immunogold labeling. Discrete points of contact were detected in the
granular and horny layers. Morphometric approach indicated that the total thickness of lipid
membranes forming these points was slightly inferior to the sum of thicknesses of two individual
membranes, suggesting molecular fusion within the structures. We propose that TJ-like points of
adhesion distributed at the periphery of the flattening cell disks contribute to the reinforcement of
lateral contacts and to the formation of plasma membrane interdigitations at this localization.
Persistence of these structures, immobilized through the cross-linking of cornified envelopes, may
result in the increased lateral cohesion between corneocytes in the stratum corneum compactum.
This could explain the differences in degradation rates between the ‘‘central’’ and ‘‘peripheral’’
corneodesmosomes observed during physiological desquamation.
O18
Formation and function of epidermal tight junctions in a
reconstructed skin model
A. Schrader, J. Hoffmann, T. Blatt, H. Wenck, K.-P. Wittern, U. Breitenbach. Beiersdorf AG,
Hamburg, Germany; CellSystems Biotechnologie, St Katharinen, Germany
Little data are available regarding the function, formation, and underlying regulatory
mechanisms of the tight junction complex in human epidermis. The present investigation
describes for the first time EST-1000 models (CellSystems Biotechnologies, St Katharinen,
Germany) at the age of 11 days as an in vitro three-dimensional skin equivalent qualified to
monitor tight junctions in vitro. Histological staining of EST-1000 models (days 13–15 after airlift)
analyzing occludin and claudin-1 shows a very distinct distribution of these essential tight
junction markers in the reconstructed epidermis. Furthermore, western blot analysis confirmed
these histological findings, indicating the increase in claudin-1, occludin, and the intracellular
adaptor protein zo-1 concentrations during the differentiation process of the three-dimensional
model. Investigating the functionality of the tight junction complex, the transepithelial electrical
resistance (TEER) was monitored. As a measure of tight junction density, certifying the formation
of intact tight junction, the TEER increases as the differentiation process of the model continues.
These data prove for the first time the development and function of the tight junction complex in a
three-dimensional skin equivalent and emphasizes the EST-1000 skin model (11 days of airlift) as
an excellent in vitro system for monitoring the formation, function, and regulation of epidermal
tight junctions.
O19
Identification and characterization of a new isoform of Kazrin:
expression and localization during epidermal differentiation
R. Nachat, L.-M. Sevilla and F.-M. Watt. Epithelial Cell Biology Laboratory, Cancer Research UK,
Cambridge Research Institute, Cambridge CB2 0RE, UK
Kazrin was identified in our laboratory as novel periplakin-interacting protein using the yeast
two-hybrid system. There are four alternatively spliced transcripts, encoding three proteins with
different NH2 termini (Kazrin A, B, and C, J Cell Biol 2004, 166: 653–9). Recently, we identified a
novel isoform that belongs to the liprin protein family. This isoform is designated as Kazrin L (for
liprin) and it contains six additional 30 exons. The Kazrin L cDNA is 2,326 bp and encodes a
protein of 775 amino acids. The COOH terminus contains three SAM domains (sterile a-motif
domain) and a PDZ-binding motif, known to be involved in protein–protein interactions.
Although the function of Kazrin isoforms is still unknown, we show that all isoforms localize at
cell–cell borders and nuclei of keratinocytes in culture and in the living layers of the epidermis.
Human keratinocytes overexpressing Kazrin L, through retroviral infection, present an
upregulated expression of the late differentiation markers involucrin and transglutaminase 1.
Morever, we showed that the knock-down of Kazrin gene expression in human keratinocytes
induces cellular proliferation and inhibits differentiation. These preliminary results suggest that
Kazrin L may play a function in the regulation of epidermal differentiation.
O20
Revisiting hypotrichosis simplex of the scalp as a new human
amyloidosis. Involvement of a Gly/Ser-rich domain of
corneodesmosin in the fibrillogenesis
C. Caubet1, L. Bousset2, R.-C. Betz3, A. Bygum4, O. Clemmensen4, J. Mazereeuw-Hautier1, R.
Melki2, M. Simon1, G. Serre1. UMR 5165 CNRS-University of Toulouse III, Toulouse, France;
2LEBS, CNRS, Gif-sur-Yvette, France; 3Institute of Human Genetics, University of Bonn, Bonn,
Germany; 4Department of Dermatology, Odense University Hospital, Odense, Denmark
Corneodesmosin (CDSN) is specifically expressed in the most differentiated keratinocytes of
the epidermis and the hair follicles. Heterozygous nonsense mutations of the CDSN gene cause
hypotrichosis simplex of the scalp (HSS), a rare human disease characterized by non syndromic
alopecia. The resulting truncated proteins include the adhesive Gly/Ser–rich domain of CDSN and
accumulate abnormally as high order assemblies in the dermis of patients. In this work, we reveal
common features between CDSN mutant aggregates and amyloid ones, supporting HSS as a
potential new amyloid disease. On skin sections of HSS patients, we show that CDSN aggregates
display affinity for amyloidophilic dyes (Congo red and thioflavin T) and are associated with SAP,
an amyloid secondary component. Recombinant forms of CDSN mutants and of the Gly/Ser–rich
domain appeared to assemble into proto-fibrillar structures or in long mature fibers, respectively.
The amyloid-like nature of the fibrils was confirmed by amyloid dye binding assays. The
protofibrillar forms generated in vitro are toxic to keratinocytes. The thorough structural
characterization of the fibrils is underway. This work aims to better understand HSS
pathophysiology and may contribute to the identification of pro-amyloidogenic sequences
responsible for assembly of CDSN into protein fibrils.
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O21
Corneodesmosin, an essential actor of the epidermis barrier and
the hair follicle integrity
E. Leclerc1, N. Jonca1, A. Huchenq1, N. Mattiuzzo1, L. Gazeilles1, M.-F. Galliano1, N.
Ghyselinck2, D. Metzger2, P. Chambon2, M. Guerrin1, G. Serre1. 1UMR5165 UDEAR—CNRS/
UPS – Toulouse, France; 2IGBMC—Strasbourg, France
Corneodesmosin (CDSN) is an adhesive protein, specific to corneodesmosomes, the
specialized junctional structures responsible for cohesion in the stratum corneum. CDSN is also
expressed in the inner root sheath of the hair follicles. Accordingly, CDSN nonsense mutations are
responsible for a rare monogenic autosomal-dominant disease, hypotrichosis simplex of the scalp
(OMIM #146520). To investigate the role of CDSN in vivo, we developed Cdsn-deficient mice,
using the keratin 14-driven Cre-mediated LoxP recombination. Heterozygous mice show no
visible phenotype, suggesting that hypotrichosis simplex of the scalp is not the result of
haploinsufficiency. On the contrary, Cdsn/ mice suffer from dramatic epidermal fragility and
die within hours after birth. Functional studies showed a drastic barrier defect and loss of stratum
corneum mechanical resistance. Structural and ultrastructural analyses revealed that cohesion is
disrupted at the stratum granulosum/stratum corneum junction upon minor mechanical stresses.
To evaluate the long-term phenotype of Cdsn/ mouse epidermis, we grafted KO mouse skin
onto Nude mice. The grafted epidermis showed a dramatic barrier defect despite onset of
hyperproliferation, hyperkeratosis, and parakeratosis. Moreover, the hair follicles underwent
progressive degeneration. Altogether, these data show the essential role of Cdsn in maintaining
the epidermis barrier and hair follicle integrity.
O22
Criteria for selecting a biological treatment in patients with
psoriasis: 63 cases
A. Maza, N. Meyer, F. Rimareix, M. Lahfa, J. Mazereeuw-Hautier, M.-C. Marguery, C. Livideanu,
A. Ammoury, R. Viraben, C. Paul. Dermatology, CHU of Toulouse and University of Toulouse III,
Toulouse, France
This study, performed over an 18-month period, evaluated the factors influencing the choice
of a biological therapy for psoriasis. For all the patients treated by biological therapy, we noted
the following: demographics, comorbidities, severity, type of psoriasis, quality of life (DLQI) and
depression (BECK). A total of 63 patients (etanercept, n¼ 27; infliximab, n¼ 19; and efalizumab
n¼ 19) were evaluated with mean PASI 23±14.5 and mean DLQI 13.8±7.8. There was no
significant difference on PASI and DLQI among the three groups and also between patients
treated with anti-TNFa vs efalizumab. The Beck’s index (depression) was higher in patients
treated with infliximab as compared with patients treated with etanercept or efalizumab
(P¼ 0.04). Patients with psoriatic arthritis received more frequently anti-TNFa (50 vs 10.5% -
efalizumab-, P¼ 0.001). Ethylism was more frequent in patients treated with anti-TNFa (29.5 vs
5.3% -efalizumab-, P¼ 0.001). In addition, patients with liver disease received preferentially TNF
antagonists (11.3% under anti-TNFa vs 0 sub-efalizumab, P¼0.01). The three patients with a
history of cancer have all received treatment with efalizumab. The choice of a biological
treatment for psoriasis seems to be more influenced by comorbidities (ethylism, depression,
rheumatism, and hepatopathy) and personal history (cancer) than by the severity of the psoriasis.
O23
Effect of folic acid supplementation on methotrexate toxicity:
review of the literature
S. Prey, C. Paul. Dermatology, CHU of Toulouse and University Toulouse III, Toulouse, France
Methotrexate (MTX) is a standard systemic therapy of psoriasis and rheumatoid arthritis. Folic
acid supplementation has been advocated to limit the toxicity of MTX. However, there is still
controversy regarding the usefulness of folic acid supplementation. We sought to assess the
evidence for efficacy of folic acid supplementation in patients treated by MTX for inflammatory
diseases. We also investigated whether folic acid supplementation may decrease the efficacy of
MTX. Cochrane and MEDLINE databases were systematically searched. Double-blind rando-
mized placebo-controlled trials in patients treated by MTX for rheumatoid arthritis, psoriasis, with
or without arthritis were included. Seven randomized controlled trials met the inclusion criteria,
with a total sample of 701 patients. The statistical analysis showed a significant reduction of
35.8% of hepatic side effects induced by MTX for patients with supplementation with folic or
folinic acid (95% CI: 0.248 to 0.467). There was no statistical difference for muco-cutaneous
and gastro-intestinal side effects. The effect of supplementation on hematological side effects
could not be assessed accurately due to low incidence of these events in the population studied.
We were unable to analyze the effect of supplementation on the effectiveness of MTX, as markers
of activity used in each study were not comparable. Supplementation with folic acid is an
effective measure to reduce hepatic adverse effects associated with MTX treatment. There is no
difference between folinic acid and folic acid, but the lower cost of the latter promotes its use.
O24
Concomitant epidermal and endothelial apoptosis in five toxic
epidermal necrolysis and three severe acute GVHD
L. Verneuil, P. Ratajczak, C. Allabert, C. Leboeuf, F. Comoz, J.-C. Ameisen, A. Janin.
Dermatology, CHU CAE andt INSERM U552, Caen, France
Toxic epidermal necrolysis (TEN) is characterized by an extensive keratinocyte apoptosis
with perforine/granzyme B and Fas/FasL expressions in situ, as in the severe allogeneic aGVHD
(acute graft-versus-host disease). Moreover, in aGVHD, FasL-mediated endothelial apoptosis has
been shown. We have investigated whether endothelial apoptosis is associated with keratinocyte
apoptosis in TEN and detected cytotoxic protein expression in situ. Five TEN and three aGVHD
are studied and compared with five normal skins and five drug urticaria. In keratinocyte and
endothelial cells, apoptotic cells have been characterized by electron microscopy, TUNEL assay,
and cleaved caspase 3 immunostaining. Inflammatory cells have been characterized, quantified,
and FasL, granzyme B, TNF-a expressions have been studied. In the five TEN, we show an
endothelial apoptosis of dermal vessels with T lymphocytes and macrophages infiltrate expressing
FasL and granzyme B, such as in severe aGVHD. On the other hand, keratinocyte apoptosis
injures whole epidermal layers in TEN, whereas keratinocyte in the tips of rete ridges are preferred
targets in severe aGVHD. Normal skin and urticaria show apoptotic bodies in granular epidermal
layer. In two severe dysimmune syndroms involving T lymphocytes, we proved concomitant
epidermal and endothelial apoptosis with FasL expression in situ. Endothelial injuries recognition
is important because these can increase epidermal lesions and contribute to other organs
damages.
O25
Regressive melanomas and sentinel lymph node biopsy: a
cohort of 173 cases
N. Meyer1, Y. Socrier1, L. Lamant2, I. Garrido4, F. Lauwers3, R. Lopez3, C. Chevreau4, R.
Viraben1, C. Paul1. 1Dermatology, 2Anatomopathology, 3Surgery; CHU of Toulouse, University
Toulouse III, Toulouse, France. 4Institut Claudius Regaud, Toulouse, France
The prognostic value of the regression of a melanoma is not well known. The interest of
performing a sentinel lymph node (SLN) biopsy for regressive melanomas (RM) has been
evaluated by only one good study (84 cases). We have compared the frequency of lymphatic
metastases in RM vs non-RMs (NRM). We performed a cohort study and collected the following
data: thickness (Breslow), regression, and histological status of the SLN. Subjects were sorted in
two groups (RM/NRM). A stratified analysis (Breslow o1 mm or X1 mm) was performed. We
determined the odds ratio of the risk of detecting a metastasis of the SLN. A total of 173 patients
were studied, 59 presented a RM and 44 had metastasis of the SLN. Overall, 29.8% of the NRM vs
16.9% of the RM had metastases of the SLN (OR¼ 0.48; 95% CI: 0.2–1.06). For the o1 mm
melanomas, OR was 0.50 (95% CI: 0.07–3) and 1.024 (95% CI: 0.35–3) for the X1 mm
melanomas (n¼ 122). The protective value of the regression on the risk of SLN metastasis
disappears in the X1 mm melanomas group. Regression seems not to be independent of the
Breslow for the risk of SLN metastasis. Regression of a primitive melanoma seems not to be
independent of the Breslow index to predict the risk of lymphatic metastasis.
O26
Differences between segmental and non-segmental vitiligo in
childhood: a French prospective study
J. Mazereeuw-Hautier1, E. Mahe2, C. Bodemer3, C. Eschard4, V. Viseux5, C. Labreze6, P. Plantin7,
J.-F. Stadler8, P. Vabres9, L. Martin10, C. Paul1, J.-P. Lacour11. Dermatology, 1CHU of Toulouse,
University Toulouse III, Toulouse, France; 2Hospital Ambroise Pare´, 3Hospital Necker, Paris,
France; 4CHU Reims, Reims, and 5Hospital of Amiens, Amiens, France; 6CHU Bordeaux,
7Hospital of Quimper, 8Hoˆtel Dieu, Nantes, 9Hospital of Dijon, 10Hospital of Angers and
11Hospital Archet 2, Nice, France
Segmental vitiligo (SV) is supposed to display different characteristics compared with non-SV
(NSV), but there are no studies comparing both forms. The aim of this study was to compare SV
and NSV in a large French cohort of childhood vitiligo patients. All children with vitiligo seen
between 1 October 2005 and 31 December 2007 in 11 French Department of Dermatology were
included in this prospective study. A standardized questionnaire was filled. The characteristics of
NSV and SV were compared. A total of 114 children were included, 25 had SV (22%) and 89 had
NSV (78%). Between both groups, we noted some differences (Po0.05), such as number of
lesions (o5 plaques: SV 80% vs NSV 35%), involved body surface area (SV 3.5% vs NSV 9.8%),
hyperpigmentation of the border (SV 0% vs NSV 9%), Koebner’s phenomenon (SV 24% vs NSV
4.2%), thyroid abnormalities (SV 0% vs NSV 13%), and progression of the disease (mean follow-
up 13.6±6.8 months; SV 5.5% vs NSV 23.3%). We report the first French prospective study on
childhood vitiligo, specifically comparing SV with NSV. This study shows differences between
both forms. These results further enhance the hypothesis of a different pathophysiology.
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O27
Blue-gray photodistributed hyperpigmentation induced by
amiodarone deposits in the skin: role of vacuolar ATPase in the
formation of amiodarone-containing vacuoles and
macroautophagy transition of this cytopathology
A. Ammoury1, G. Morisette2, R. Lodge2, M.-C. Marguery1, C. Paul1, F. Marceau2. 1Dermatology,
Hospital Purpan, CHU of Toulouse, Toulouse, France. 2Centre Hospitalier Universitaire de
Que´bec, Que´bec, Canada
This study describes the mechanism of amiodarone sequestration mediated by vacuolar
ATPase and the macroautophagic transition of the resulting vacuoles. Amiodarone sequestration
into HEK 293A cells was measured using its violet fluorescence. Transfection of coding vectors for
subcellular markers conjugated to the green fluorescent protein (GFP) allowed vacuoles
characterization. Macroautophagy signaling was evaluated by immunoblot of the effector LC3.
A skin biopsy was performed on a hyperpigmented facial skin of a patient treated with
amiodarone to verify the presence of macroautophagy. In HEK 293A cells, amiodarone induced a
vacuolar morphology. Amiodarone-induced vacuoles were positive for late endosome/lysosome
markers (GFP-Rab7, CD63) and for the macroautophagy effector GFP-LC3. A paraffin-
embedded hyperpigmented skin specimen of the patient showed positive vacuoles accumulating
LC3, especially inside the macrophages of the superficial dermis. Amiodarone induced vacuoles
that evolve toward persistent macro-autophagosomes. Thisstudy shows LC3 stain in the
macrophages that can be a privileged site for amiodarone sequestration because they are rich
in acidic organelles.
O28
Implication of c-kit variants in genetic predisposition to
melanoma
A. Bourillon1, J.-J. Lacape`re2, V. Descamps3, C. Lebbe4, N. Basset-Seguin4, P. Wolkenstein5, N.
Dupin6, P. Saiag7, B. Grandchamp1, N. Soufir1. 1Laboratoire de Biochimie Hormonale et
Ge´ne´tique, Hospital Bichat, APHP; IFR02 and 2EA3516, University of Paris 7, Paris, France;
3Dermatology, Hospital Bichat, APHP, University of Paris 7, and 4Dermatology, Hospital Saint
Louis, APHP, Paris, France; 5Dermatology, Hospital Henri Mondor, APHP; 6Dermatology,
Hospital Tarnier, APHP, Paris, France and; 7Dermatology, Hospital Ambroise Pare´, APHP,
Boulogne, France
The KIT receptor is a protein kinase that plays a crucial role in melanocyte differentiation and
migration. Loss-of-function constitutional mutations are responsible of piebaldism, whereas
germline activating c-kit mutations predispose to mastocytosis and gastrointestinal stromal
tumour. We searched for c-kit variants in predisposition to melanoma. We sequenced the entire
coding sequence of c-kit in 143 patients affected by familial melanoma and/or multiple
melanoma, and 189 Caucasian controls. Non-synonymous variants were analyzed in silico with
Sift, Polyphen, Panther, SNPs3D sites, and Pymol softwares. A total of 10 non-synonymous
variants were found, 5 in melanoma patients and 5 in controls. Variants were localized in the
extracellular, transmembrane, and kinase KIT domains. Interestingly, in patients, all five non-
synonymous variants were predicted to be deleterious in silico by at least two prediction
bioinformatic programs, whereas none in controls (Fisher’s exact test¼0.01). These results were
reinforced by studying the effects of variants using Pymol software, all variants found in patients
being predicted to affect KIT function. These results suggest a role for c-Kit in predisposition to
melanoma, but functional studies are needed to better precise the effects of these variants on
melanocyte physiology.
O29
Validation of the use of small amounts of DNA extracted from
formalin-fixed and paraffin-embedded metastatic melanomas
for high-resolution array-based CGH
E. Frouin1,2, M. Legrain2, M. Guenneugues3, A. Neuville4, J.-P. Kerckaert5, N. Wicker6, B.
Cribier1, M.-P. Gaub2, P. Oudet2. 1Dermatology and 2Laboratoire de biologie mole´culaire,
Strasbourg, France; 3Cance´ropoˆle du Grand Est, 4Department of Anatomy and Pathology,
Strasbourg, France; 5Institut de Recherche sur le Cancer de Lille, Lille, France; 6Laboratoire de
Bioinfomatique et de Ge´nomique Inte´grative IGBMC, Illkirch-Grafenstaden, France
The ability to utilize small amounts of DNA extracted from formalin-fixed, paraffin-
embedded (FFPE) archival specimens for high-resolution molecular genetic analysis would be a
very helpful tool in the study of human melanoma. In this study, we compared genomic DNA
extracted from 15 matched fresh-frozen and FFPE metastasis of melanoma. We first determined
quality criteria required to predict the samples that could be used in array-based comparative
genomic hybridization and we determined the optimal amount of DNA that can be amplified
without introducing allelic bias. Then we hybridized fresh-frozen and FFPE DNAs obtained from
five matched melanoma metastases before and after whole genome amplification on the
AGILENT 44K microarray. There were no significant differences (Pearson’s R240.900). These
results indicate the ability to use amplified genomic DNA extracted from FFPE samples in high-
resolution array-based comparative genomic hybridization.
O30
GLI2, A TGF-b-inducible target, antagonizes M-MITF and
promotes melanoma aggressiveness
D. Javelaud1*, V-.I. Alexaki1*, L. Van Kempen2, K.-S. Muhammad, S. Dennler1, F. Luciani4, K.
Hoek5, P.-.J. Fournier3, J.-S. Goydos6, C. Sibon7, C. Bertolotto8, F. Verrecchia1, S. Saule4, V.
Delmas4, R. Ballotti8, L. Larue4, P. Saiag7, T.-A. Guise3, A. Mauviel1. 1INSERM U697, Paris,
France; 2U. Niejmegen, The Netherlands; 3U. Virginia, Charlottesville, Virginia, USA; 4UMR146
CNRS, Institut Curie, Orsay, France; 5U. Zurich, Switzerland; 6New Brunswick, New Jersey, USA;
7Hospital Ambroise Pare´, Boulogne; and 8INSERM U597, Nice, France. These authors equally
contributed to this work
The melanocyte-specific transcription factor M-MITF is involved in all aspects of melanoblast
lineage biology. Its expression in melanoma is highly variable. In this study, we show that
expression of GLI2, an Hedgehog mediator also identified as a transformation growth factor
(TGF)-b/Smad target, greatly varies in melanoma and is inversely correlated with that of M-MITF.
Both transcription factors exert reciprocal inhibitory activity against each other’s expression. The
balance between M-MITF and GLI2 expressions is controlled by the TGF-b/Smad pathway that
favors GLI2 expression, whereas the protein kinase A/cAMP pathway tilts the balance toward high
M-MITF expression. High GLI2 expression in melanoma cell lines is correlated with loss of
melanocytic differentiation markers, greater migration, and invasiveness, together with loss of E-
cadherin expression. GLI2 expression directly controls melanoma cell metastatic potential in a
mouse model of bone metastasis. Remarkably, in human melanoma samples, GLI2 expression is
heterogeneous, yet inversely correlated with that of E-cadherin, and is strongly increased in the
most aggressive tumors.
O31
Silencing of the proprotein convertase PACE4 by siRNA strategy
affects the human primary melanoma malignant phenotype
A. Imbard, C. Lalou, S. Mourah, M.-P. Podgorniak, N. Basset-Seguin, A.-M. Khatib. INSERM,
U716, Institut de Ge´ne´tique Mole´culaire, and University Paris 7, Paris, France
The proprotein convertases (PCs) are a family of serine proteases, namely PC1, PC2, Furin,
PC4, PACE4, PC5, and PC7. These enzymes are required for activation of various protein
precursors involved in the malignant phenotype of tumor cells. These include growth factors, their
receptors, adhesion molecules, and several proteases. Analysis of primary human melanoma M10
cells revealed the presence of all the PCs found in the secretory pathway with a high expression
level of PACE4 as compared with normal melanocytes. To evaluate the role of PACE4 in
melanoma malignant phenotype, we targeted the expression of this convertase by siRNA strategy.
Of the siRNA assessed, two were able to mediate up to 80% inhibition of PACE4 expression.
Transfection of M10 cells with PACE4 siRNA inhibited the processing of the convertase substrate
IGF-1 receptor. This was associated with a reduction in M10 cell proliferation and migration.
Zymography analysis revealed a reduced activity of matrix metalloproteinase (MMP)-2 and MMP-
9 in the transfected cells. This was correlated with upregulated expression of their naturally
occurring inhibitors tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-1, respectively.
Taken together, these data highlighted the importance of PACE4 in the regulation of melanoma
malignant phenotype and suggest the use of PACE4 silencing or inhibitor as a potential
therapeutic strategy melanoma.
032
In vivo and in vitro modulation of melanoma progression by IP-
10
F. Antonicelli, J. Lorin, W. Hornebeck, F. Grange, P. Bernard. Laboratoire de Dermatologie,
URCA, CNRS UMR6237, Reims, France
Host immune response and tumoral growth are highly intricate mechanisms. We here sought
the relationship between melanoma progression, the profile of cytokine production by circulating
lymphocytes, and the capacity of these lymphocytes to modulate melanoma invasiveness. The
study was performed using blood lymphocytes from healthy donors (group 1), patients with
melanoma o1 year and clinical remission (group 2), or with metastatic melanoma (stages III–IV
AJCC-UICC, group 3). Purified lymphocytes from heparinized venous blood were either used
directly or seeded at 106 cells/ml in six-well plates for 6 hours. Cytokines were determined using
the Luminex technology and specific ELISA. SK-Mel28 melanoma invasiveness was measured
in vitro using Transwell chamber model coated with Matrigel, either after co-culture with
lymphocytes or with lymphocyte culture media. Both co-culture with lymphocytes and addition
of lymphocyte culture medium inhibited melanoma invasiveness, showing the essential role of
secreted factors for this modulation. These effects were stronger with lymphocytes from group 2
than with those from group 3 (60 and 40%, respectively, compared with control). Among 30
secreted cytokines screened, only IP-10 level was higher in group 2 compared with group 3.
Although addition of rIP-10 alone did not reproduce the lymphocyte regulatory effects on
melanoma invasiveness, its effect was amplified by Rantes co-stimulation, another chemokine
whose level did not significantly vary between patients groups. Hence, IP-10 secretion level could
constitute a prognostic factor of melanoma progression that still needs further investigation.
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Transmission of KID syndrome by a mosaic parent for a GJB2
mutation
M. Titeux1*, V. Mendonc¸a3*, A. De´cha1, E. Moreira3, S. Magina3,4, A. Maia3, L. Lacaze-Buzy2,5,
J.-E. Mejı´a1, L. Torra˜o3,4, F. Carvalho4, J. Ec¸a-Guimara˜es3,4, A. Hovnanian1,2,5. 1INSERM U563,
and 2Reference Centre for Rare Skin Diseases, Toulouse, France; 3Sa˜o Joa˜o Hospital and
4University of Porto School of Medicine, Porto, Portugal; 5Purpan Hospital, Department of
Medical Genetics, Toulouse, France. *These authors equally contributed to this work
KID syndrome associates keratitis, ichthyosiform lesions, and neurosensory deafness. KID
syndrome is caused by dominant, often sporadic mutations in the genes GJB2 and GJB6,
respectively, encoding connexins 26 and 30 of gap junctions. Over 80% of known cases are
caused by the recurrent p.D50N mutation of GJB2. We describe the first instance of KID
syndrome transmission from a mosaic parent. The proband was a 27-month-old boy born to non-
consanguineous parents. He presented since birth with generalized, pronounced ichthyosiform
lesions, onychodystrophy, and absent scalp hair, eyebrows, and eyelashes. Deafness was
clinically detected, and he developed bilateral corneal opacification. The father was healthy,
whereas the mother displayed hyperkeratotic, hyperpigmented, segmental lesions along the
Blaschko lines. Leukocyte DNA showed heterozygosity for the p.D50N mutation of GJB2 in the
patient but not in his parents. The mutation, however, was detectable in the mother’s lesional skin
DNA, suggesting mosaicism. This was confirmed by molecular cloning. KID syndrome is thus a
member of a growing group of genodermatoses with segmental manifestations arising from
mosaicism. These involve a risk of inheriting a generalized form of the disease from a parent who
is a gonadal mosaic.
O34
Polymorphisms of the XP variant gene (POLH) increase
melanoma risk
J. Di lucca1, M. Guedj2, J.-J. Lacape`re3, A. Bourillon1, C. Combadie`res4, M. Rodero4, P. Dieude´5,
V. Descamps6, N. Dupin7, P. Wolkenstein8, P. Aegerter9, C. Lebbe10, N. Basset-Seguin10, P.
Saiag11, B. Grandchamp1, N. Soufir1. 1Laboratoire de Biochimie Hormonale et Ge´ne´tique,
Hospital Bichat, APHP, University of Paris 7; 2Ligue Nationale Contre le Cancer, 3Inserm U773,
4Inserm U543, 5Rhumatology, Hospital Bichat, APHP, Paris, France; 6Dermatology, Hospital
Bichat, 7Dermatology, Hospital Tarnier, 8Dermatology, Hospital Henri Mondor, 9URC, Hospital
Ambroise Pare´, 10Dermatology, Hospital Saint Louis, and 11Dermatology, Hospital Ambroise
Pare´, APHP, Paris, France
Xeroderma pigmentosum variant (XPV) is a genodermatosis predisposing to early onset and
multiple skin cancer. XPV results from bi-allelic mutations of the POLH gene that encodes a DNA
translesion polymerase. We investigated the role of POLH in predisposition to melanoma by two
complementary approaches: (1) genotyping of a non-synonymous POLH variant, c.1783A4G
p.M595V, in 1075 patients and 1091 controls and (2) Search for rare variants by sequencing the
POLH coding sequence in 206 patients and 170 controls. The p.M595V variant was significantly
more frequent in patients than in controls (allelic frequencies 0.040 vs 0.022, P¼ 1.16 103,
OR¼1.86 (1.27–2.7)). Three non-synonymous and rare variants were only detected in patients:
c.295G4A V99M, c.815T4C I272T, and c.1745C4T S582L. In silico prediction tools and three-
dimensional structure study suggested that these variants could have a functional impact.
Together, these data strongly support a role for POLH in multifactorial predisposition to
melanoma.
O35
Nonsense-mediated mRNA decay is involved in the degradation
of CGI-58 transcript in patients with Dorfman–Chanarin
syndrome and 773-1G4A mutation
N. Bouzaiene1, P. Schischmanoff2, Z. Ben Selma1, A. Blom3, L. Laroche3, F. Caux1,3. 1INSERM
ERI18, University Paris XIII; 2Biochemistry and 3Dermatology, CHU Avicenne, Bobigny, France
Nonsense-mediated mRNA decay (NMD) is an mRNA surveillance system that degrades
transcripts containing premature termination codons to prevent translation of aberrant transcripts.
In humans, NMD has been shown to modify the mode of inheritance and the clinical phenotype
in genetic diseases. Here we showed for the first time this mechanism in patients with the
Dorfman–Chanarin syndrome (DCS).
In three DCS Tunisian patients, a homozygous G-to-A transition at position 773 1 was
observed. In silico splice site analysis predicted the suppression of the acceptor splice site at the
intron 5/exon 6 boundary and the appearance of a cryptic splice site 95 nucleotides later. This
shortened transcript predicted a truncated 323-amino acid protein (instead of 349 amino acids)
including 65 C-ter missense amino acids. Reverse transcription (RT)-PCR using one patient’s
mRNA revealed a shortened amplicon with decreased intensity whose sequencing showed the
deletion of the first 95 nucleotides of exon 6. Quantitative RT-PCR confirmed a decreased level of
transcripts in patient vs controls (11.6±1 and 40.2±2.7, respectively; Po0.001, n¼4).
Inhibition of NMD by puromycin 200mg ml1 increased transcripts level in treated cells vs
untreated cells (29.3±1.3 and 17±2.8, respectively; Po0.01, n¼ 6).
In conclusion, we reported that NMD is responsible for mRNA degradation in some patients
with DCS and may be inhibited by chemical agents offering new therapeutic prospects.
O36
MMP1 is a major modifier gene in recessive dystrophic
epidermolysis bullosa
M. Titeux1, V. Pendaries1, L. Tonasso1, A. De´cha1, C. Bodemer2, A. Hovnanian1,3. 1INSERM,
U563, Toulouse, 2Hoˆpital Necker, Paris and 3CHU Purpan, Toulouse, France
Recessive dystrophic epidermolysis bullosa (RDEB) is caused by loss-of-function mutations in
COL7A1 encoding type VII collagen. A great clinical heterogeneity ranging from localized forms
to the generalized mutilating Hallopeau–Siemens type is observed among RDEB patients. This
variability in the severity is likely to depend on the nature and location of COL7A1 mutations, but
the observation of intrafamilial phenotypic variations suggests additional genetic and/or
environmental factors. Candidate modifier genes include MMP1 encoding matrix metalloprotei-
nase 1 (which degrades type VII collagen), the first gene implicated in RDEB before its primary
role in the disease could be excluded. Here we studied a multiplex family with three affected
siblings sharing an identical COL7A1 genotype but displaying contrasted disease severities. We
show that the differences in severity do not correlate with type VII collagen expression, but rather
with the amount of the protein detectable at the dermal–epidermal junction, suggesting an
increased degradation rate of the protein by metalloproteinases. We show that the two most
affected offspring carry a known single nucleotide polymorphism (1G/2G) in the MMP1 promoter,
which results in the upregulation of the gene. We next studied a French cohort of 31 unrelated
RDEB patients having at least one inframe COL7A1 mutation sorted by clinical subtypes and
found that the 2G allele was more frequent in the most severe phenotypes (OR: 73.6). This is the
first modifier gene identified in RDEB and has implications for its prognosis and possible new
therapeutic intervention.
O37
Murine models to decipher Netherton’s syndrome
pathophysiology
C. Deraison1,2, C. Bonnart1, A. Briot1, M. Lacroix1, A. Robin1, C. Besson1, A. Hovnanian1,2.
1INSERM U563, Toulouse, France; 2Reference center for orphan skin diseases, Department of
Medicals Genetics, CHU Purpan, Toulouse, France
Netherton’s syndrome (NS) is a rare genetic life-threatening skin disease characterized by a
scaly erythroderma, specific hair anomalies (trichorrhexis invaginata or bamboo hair), and severe
atopic manifestations. We have shown that NS is due to loss of expression of SPINK5 gene,
encoding the multidomain serine protease inhibitor LEKTI. The study of Spink5/ mice model
has established that LEKTI plays a crucial role in skin homeostasis by regulating the activity of the
epidermal proteases KLK5, KLK7, and the newly identified elastase 2 (ELA2). To decipher the
specific contribution of each protease in the NS phenotype, we developed transgenic mouse
models overexpressing these proteases in the epidermis. The analysis of Tg-Ela2 mice shed light
on essential functions of this new epidermal protease in cutaneous biology and in skin barrier
protection, with direct effects on filaggrin and interconeocyte lipid processing. KLK5 transgenic
mice revealed that this protease initiates the biological cascade leading to major clinical features
of NS, thus identifying KLK5 as a promising target for a specific therapy for NS.
O38
A bipartite long-range enhancer recruits distinct AP-1 factors to
control transcription of the peptidylarginine deiminase-3 gene
during keratinocyte differentiation
V. Adoue1, S. Chavanas1, F. Coudane1, M.-C. Me´chin1, C. Caubet1, S. Ying2, S. Dong2, H.
Duplan3, M. Charveron3, H. Takahara2, G. Serre1, M. Simon1. 1UMR5165, CNRS-UPS, Toulouse,
France; 2Ibaraki University, Ibaraki, Japan; 3Institut de Recherche Pierre Fabre, Toulouse, France
Peptidylarginine deiminases (PADs) catalyze deimination, a calcium-dependent post-
translational modification. They are encoded by five PADI genes clustered in position
1p35–36. Only PAD1–3 are found in the epidermis with an increased expression rate in the
most differentiated keratinocytes. Previous characterization of PADI proximal regulatory elements
had failed to explain this specificity of expression. In this study, we identified two DNase I-
hypersensitive sites, PIE-S1 and PIE-S2, located 81 kb from PADI3. PIE-S1 and PIE-S2 act
synergistically to enhance the PADI3 promoter activity in differentiated normal human epidermal
keratinocytes (NHEK). They present all characteristics of the enhancers, such as orientation
independence, copy-number dependence, and cell-type-specific activity. PIE-S1 and PIE-S2
comprise conserved putative binding sites for MIBP1/RFX1 and activating protein 1 (AP-1),
respectively. Deletion mutants screening and gel shift assays revealed that these sites actually
bind proteins from NHEK nuclear extracts and are crucial for the enhancer activity. Furthermore,
chromatin immunoprecipitation assays evidenced binding of JunD or c-Jun on the AP-1 site,
according to the differentiation state of NHEK. Our results reveal a model to explain the
expression specificity of PADI3 and probably of PADI1 during Ca2þ -induced keratinocyte
differentiation through a bipartite long-range enhancer, the activity of which is dependent on a c-
Jun/JunD competition.
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Regulatory B cells: a new player in contact dermatitis regulation
J.-D. Bouaziz, K. Yanaba, T.-F. Tedder. Service d’immunologie, Duke University Medical Center,
Durham, NC, USA; Unite´ INSERM 841, Hoˆpital Henri Mondor, Cre´teil, France
B cells play multiple roles in inflammatory disease pathogenesis, namely Ab production
(plasma cells), cellular adjuvant for CD4þ T-cell activation, and immune tolerance. Contact
dermatitis was induced by topical application of oxazolone in wild-type mice, mice with hyper-
reactive B cells, mice with hyporeactive B cells, and mice depleted of B cells using an anti-mouse
CD20 mAb. The differences in contact dermatitis intensity in these different mice and the
mechanisms underlying them were studied. Contact dermatitis reaction was diminished in mice
with hyper-reactive B lymphocytes. On the contrary, contact dermatitis was exacerbated in mice
with hyporeactive B cells and also in mice that had been B-cell-depleted using an anti-CD20
mAb. These differences were due to the existence of a unique regulatory B-cell population that
was increased in mice with hyper-reactive B lymphocytes and that was decreased in mice with
hyporeactive B cells. This regulatory B-cell population was located in the spleen, had a
CD1dhighCD5þ phenotype, and produced high quantities of IL-10 both in vitro and in vivo,
which mediated its anti-inflammatory properties. The adoptive transfer of this CD1dhighCD5þ
regulatory B-cell subset significantly reduced contact dermatitis. We have discovered a new
subset of regulatory B cells with a unique CD1dhighCD5þ phenotype. Regulatory B-cell
expansion in humans may be used in the future to modulate immune tolerance and treat several
skin inflammatory conditions such as contact dermatitis.
P2
Bioavailability and pharmacological effect of a new pentyl
rhamnoside on the inflamed skin
H. Duplan1, V. Raufast2, A. Mavon2, I. Ceruti1, N. Castex-Rizzi1, M. Charveron1,2. Laboratoires
de 1Pharmacologie et de 2Pharmacocine´tique Cutane´e, Institut de Recherche Pierre Fabre,
Toulouse, France
Atopic dermatitis is a chronic inflammatory skin disease associated with cutaneous hyper-
reactivity to environmental triggers. In response to epidermal barrier disruption and bacterial
invasion, biological signals are generated by host epidermal cells to raise locally the innate and
then the acquired immune defense systems. Keratinocytes initiate skin inflammation and recruit
immune inflammatory cells, but excessive inflammatory cell influx contributes to the
development of this inflammatory disease. We proposed to synthesize pentyl rhamnoside (PR)
in order to enhance the low epidermal absorption of rhamnose, which is known to exhibit anti-
inflammatory activities. Our objective was to determine the relevance of this chemical structure
modification in terms of skin absorption enhancement and to show its improved activity in the
modulation of uncontrolled inflammatory processes, as compared with rhamnose. A dermal
absorption study showed that o15% of rhamnose was found in the stratum corneum (SC) and
only 3% in the epidermis, whereas about 30% of PR was found in the SC and up to 8% in the
epidermis, with a specific localization in the SC lipid layers and in the keratinocyte membranes,
which was visualized with auto-historadiography. A topical treatment of staphylococcus
enterotoxin B-stimulated human skin explants with the formulated PR contributed to inhibit the
production of primary pro-inflammatory cytokines, such as IL-1, tumor necrosis factor-a, IL-6, or
IL-8 by the keratinocytes. Moreover, it decreased their RANTES (regulated upon activation,
normal T cell expressed and secreted) and ICAM-1 expression. In conclusion, we showed that the
chemical modification of rhamnose into PR provided a higher epidermal bioavailability.
P3
Induction of corticotropin-releasing hormone expression by
keratinocytes with Propionibacterium acnes extracts
O. Isard1, A.-C. Knol1, N. Castex-Rizzi3, A. Khammari2, M. Charveron3, B. Dre´no2. 1INSERM,
U892 and 2Clinique dermatologique, CHU Hoˆtel-Dieu, Nantes, France; 3Laboratoire de biologie
cellulaire cutane´e, Institut de recherche Pierre Fabre, Toulouse, France
It is widely accepted that Propionibacterium acnes plays a major role in the development of
acne especially in the inflammation stage. The corticotropin-releasing hormone (CRH) is a
neuropetide also produced by the skin (keratinocytes) through the hypothalamic–pituitary–adrenal
axis under the influence of stress. CRH had also been reported to have a role in the regulation of
cell proliferation and differentiation, which represent an important step in the development of
acne lesions. In this context, our objective was to study the modulation of CRH expression by
keratinocytes with P. acnes extracts. Immunohistochemical analysis of CRH was conducted on
frozen sections of cutaneous explants obtained from three healthy donors after three incubations
(3, 6, and 24 hours) with different P. acnes extracts (a membrane fraction and a cytosolic fraction).
We observed an induction of CRH expression by keratinocytes particularly after incubations with
the P. acnes membrane fraction, which was maximal after 3 hours. As it has been shown that P.
acnes extracts could induce filaggrine expression, by increasing CRH expression, this bacteria
could thus indirectly have an effect on keratinocytes proliferation and differentiation. This
induction was observed both with the membrane fraction and the cytosolic fraction. This study
suggests that P. acnes could be playing a role since the comedo formation and not only in the
acne inflammatory stage.
P4
Characterization of CD4þCD25high regulatory T cells in the
blood of CTCL patients treated with Bexarotene
A.-C. Knol1, G. Que´reux1,2, A. Brocard2, F. Ballanger2, A. Khammari1,2, J.-M. Nguyen3, B.
Dre´no1,2. 1INSERM U892, 2Clinique Dermatologique, CHU Hoˆtel-Dieu, and 3PIMESP, Hospital
St Jacques, Nantes, France
Cutaneous T-cell lymphoma (CTCL) are a heterogeneous group of lymphoproliferative
disorders, characterized by the infiltration of the epidermis by mature and activated malignant
CD4þ T lymphocytes. Retinoids such as retinoic acid and synthetic analogs have long been used
alone or in combination with other therapies for CTCL. Bexarotene, the first synthetic, highly
selective RXR retinoid, was approved for treatment of all stages of CTCL in patients refractory to at
least one systemic therapy. Recently, it has been established that retinoids promote the generation
of CD4þ Foxp3þ regulatory T cells (Treg cells). The involvement of Treg cells in CTCL has
already been questioned by the study conducted by Berger (Blood, 2005). The aim of this study
was to determine whether proportion and/or function of Treg cells were modified by the treatment
with Bexarotene. For this purpose, we determined proportion and functionality of circulating Treg
cells from the blood of 10 patients, before the initiation of the treatment with Bexarotene and then
3 and 6 months later. We found that CD4þCD25high Treg cells were detectable before the
beginning of the treatment with an increased frequency compared with healthy donors (6.5±2.3
vs 3.2±1.8%, P¼ 0.024), but were not significantly increased after 6 months (8.3±5.3%, not
significant, P¼ 0.1934). In addition, functional assays indicated that Foxp3-expressing
CD4þCD25high T cells were capable of suppressing autologous CD4þCD25 T-cell
proliferation. In conclusion, in this study, we detected the presence of functional circulating
CD4þCD25high Foxp3þ Treg cells in CTCL patients, with an increased frequency compared with
healthy donors.
P5
Potential anti-inflammatory properties of a new undecyl
rhamnoside on human keratinocytes
M. Le´veˆque, N. Castex-Rizzi, M. Charveron. Cutaneous Cell Pharmacology, Pierre Fabre
Research Institute, Toulouse, France
Inflammatory skin disorders, including acne, psoriasis, or the skin of patients with atopic
dermatitis, are characterized by the expression of central mediators of inflammation such as
prostaglandin E2 (PGE2) or cytokines such as IL-8. NF-kB has been shown in skin and other
organs to regulate important cellular functions, including cell proliferation and differentiation, as
well as inflammatory responses. NF-kB is a pivotal transcription factor triggering a cascade of pro-
inflammatory NF-kB target genes such as cytokines or prostaglandins. Thus, an investigation was
carried out to evaluate whether a new rhamnoside derivative namely the undecyl rhamnoside
was capable of reducing the inflammatory responses in human keratinocytes. The NF-kB
activation was assessed after tumor necrosis factor-a (TNF-a) stimulation on the human
keratinocytes cell line (HaCaT) transfected with a luciferase reporter gene ligated to a NF-kB
promoter. The NF-kB activation and translocation was assessed through the synthesis of
luciferase. PGE2 and IL-8 were produced in normal human keratinocytes after various
inflammatory stimuli. PGE2 release was mediated by phorbol 12-myristate 13-acetate (PMA)
and IL-8 by lipopolysaccharide (LPS) stimulation. Our results showed that the undecyl
rhamnoside is capable of inhibiting, in a dose-dependent manner, the transcription factor NF-
kB in TNFa-stimulated keratinocytes. Furthermore, the overproduction of IL-8 induced by LPS
was reduced by incubating the keratinocytes with the undecyl rhamnoside. PMA-mediated PGE2
release was also inhibited by the undecyl rhamnoside with 60% inhibition. NF-kB is a
transcription factor that plays a key role in the expression of many genes involved in the
inflammatory responses.
P6
Cytokine-induced CEACAM1 expression on keratinocytes is
characteristic for psoriatic skin and contributes to a prolonged
lifespan of neutrophils
M. Rahmoun1, J.-P. Mole`s2, N. Pedretti3, M. Mathieu1, I. Fremaux4, N. Raison-Peyron2, J.-C.
Lecron5, H. Yssel1, J. Pe`ne1. 1U844, Montpellier, 2Lab. Dermatologie Mole´culaire, Montpellier,
3BIOalternatives, Genc¸ay, 4U564, Angers, 5University of Poitiers, France
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a cell surface
glycoprotein, belonging to the carcinoembryonic antigen family, expressed by human
neutrophils, epithelial cells, activated T and natural killer cells. CEACAM1 is expressed as a
cell surface molecule with different isoforms or can be secreted as a soluble protein. Here, we
show that keratinocytes in the outer epidermal layer of psoriatic skin express CEACAM1, unlike
those in healthy skin or in cutaneous lesions of patients with atopic or nummular dermatitis.
Stimulation of primary human keratinocytes or in vitro reconstituted epidermis with culture
supernatants of activated psoriatic lesion-infiltrating T cells, IFN-g, or oncostatin M, but not IL-17,
induced the expression of transcripts for the CEACAM1-long and -short isoforms and cell surface
CEACAM1, whereas soluble CEACAM1 was not produced. The uppermost layers of the epidermis
in psoriatic lesions also contain neutrophils, a cell type with inflammatory and anti-microbial
properties. Co-culture of CEACAM1-expressing keratinocytes or Chinese Hamster Ovary cell
transfectants with neutrophils delayed spontaneous apoptosis of the latter cells. These results
show that cytokine-induced cell surface expression of CEACAM1 by keratinocytes in the context
of a psoriatic environment might contribute to the persistence of neutrophils and thus to ongoing
inflammation and the decreased propensity for skin infection, typical for patients with psoriasis.
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Human dermal dendritic cells are more efficient than
Langerhans cells in the polarization of CD4þ naive T cells to
Th1 cells
L. Furio, H. Billard, J. Pe´guet-Navarro, O. Berthier-Vergnes. EA 41-69, University of Lyon 1, Lyon,
France
Dendritic cells (DCs) are specialized antigen-presenting cells that belong to a heterogeneous
family of cells of hematopoietic origin. In the skin, two distinct types of myeloid DCs are found in
two distinct layers. Langerhans cells (LC) reside within the epidermis and are characterized by
langerin expression, whereas DCs, also called interstitial DCs, reside in the dermis. The precise
role of human LC and dermal DCs (DDCs) in the induction and orientation of specific cutaneous
immune responses remains obscure. In this study, LC and DDCs were isolated and purified after
migration from the same skin sample. After 48 hours, LC migrating from epidermal explants
exhibited a more mature phenotype than DDCs originating from the dermis, as evidenced by
higher cell surface expressions of CD40, CD80, CD86, and CD83. Moreover, LC displayed higher
allo-stimulating capacity than DDCs. We found that both LC and DDCs can polarize the
differentiation of allogeneic naive CD4þ T cells toward Th1 cells, although IFN-g production
induced by DDCs was significantly higher. As compared with LC, DDCs also induced high IL-10
production by CD4þ T cells. In conclusion, both human DDCs and LCs can induce Th1 T-cell
response, although DDCs seem far more efficient in this process. The concomitant IL-10
production by the CD4þ T cells might serve to limit the inflammatory reaction and subsequent
tissue damage.
P8
Impact of Dragon’s blood on an in vitro model of cutaneous
neurogenic inflammation
U. Pereira, C. Garcia-Le Gal, G. Le Gal, G. Dorange, L. Misery. EA 4326 Nerves Factors and
Tissular Structuration, University of Western Britany, Brest, France
Dragon’s blood (DB) or Sangre de drago is a viscous bright red resin collected from trees of
species Croton lechleri growing in the Peruvian jungle. This sapling is used extensively in the
pharmacopeia of Peruvian natives to treat cutaneous disorders. Its efficiency as an inhibitor of
neurogenic inflammation has been recently shown. To understand the underlying mechanism of
these effects, we examined whether DB is able to reduce the substance P (SP) release in an in vitro
model of cutaneous neurogenic inflammation (CNI). This model is based on an enzyme
immunoassay (EIA) of SP (marker of CNI) in a porcine co-culture (very close to human response)
of dorsal root ganglion neurons (DRGN) and keratinocytes (K).
After incubation with different concentrations of DB (n¼3), we noted an immediate
significant (Po0.01) dose-dependent decrease of SP basal release on average of 32% at 1% (v/v)
and 26% at 0.1% (v/v). On the other hand, the pretreatment (72 or 1 hours) of the co-culture by
DB was sufficient to induce a 111% (72 hours) or 65% (1 hour) inhibition at 1% (v/v) and a 109%
(72 hours) or 30% (1 hour) inhibition at 0.1% of artificial CNI induced by capsaicin. We conclude
that DB is a potent inhibitor of sensory afferent nerves by a direct inhibition of neuropeptide
release and support its ethnomedical use for neurogenic inflammation.
P9
‘‘From wound healing to regeneration’’: study of the
mechanisms of pulpar regeneration by occlusive dressing
S. Bakkouche, G. Lasserre, S. Robin, C. Viennet, I. Patry, X. Bertrand, P. Humbert, D. Binda, L.
Obert. Engineering and Cutaneous Biology Laboratory, Inserm U645, IFR 133, University of
Franche-Comte´, CHU Besanc¸on, Besanc¸on, France
Wounds of the fingers are quite frequent accidents ranging from a simple lesion to the
amputation of the phalanx. Many tissues are damaged, including skin, muscles, nerves, vessels,
and even bones, which can result in severe aesthetic and functional consequences. An alternative
to directed wound healing or surgical treatment consists in the application of occlusive dressings
changed every week during 3–5 weeks. This simple, economic, and effective method, used in
Besancon hospitals (France), allows a total regeneration of the phalanx. A phenomenon already
observed in reptiles or amphibians but not in humans, this process allows a complete wound
healing (20–30 days) with a return of fingerprints and a very high tactile sensibility. The objective
of this study was to determine the mechanisms influencing tissue regeneration. The dressings
collected at the time of their replacement allowed the extraction of an exudate, which was the
object of a search for microorganisms, as well as cytokines/growth factors and angiogenic factors.
Several bacteria were found besides the usual cutaneous flora, which included anaerobic
bacteria. The presence of several angiogenic factors was also found. The role in the cascade of
regeneration of every bacterium/implied factor will be determined.
P10
Collecting skin biopsies could remain a tricky affair
L. Barnes1,2, M. Dumas2, S. Schnebert2, B. Guillot1, J.-P. Mole`s1. 1Laboratoire de Dermatologie
Mole´culaire, Montpellier and 2LVMH Recherche, Saint Jean de Braye, France
Collecting biopsies still remains the source of several artefacts whose intensity is probably
underestimated. If the negative behavior of a living tissue between its excision from the donor
body and its fixation (or freezing) is well known, others factors such as anesthesia, the collecting
method, or the anatomic localization usually attract less attention. We analyzed the histological
behavior of two kinds of cutaneous biopsies in the minutes after their excision from the donor by
following three parameters, namely gH2AX (phosphorylated form of the H2AX histone), cyclin
B1, and cyclobutane pyrimidine dimers. The gH2AX showed that a chromatin stress increases
very fast in a biopsy after its excision, whereas cyclin B1 gets rapidly undetectable, reminding the
need to snap-freeze a biopsy after its excision from the donor. In the case of a mammary
cutaneous biopsy collected under general anesthesia by a de-epithelialization method, immersing
the biopsy in DMEM prevented such effects. But surprisingly, DMEM had no beneficial effects in
the case of a facial cutaneous biopsy collected by general anesthesia accompanied by a
subcutaneous injection of an anesthetic cocktail containing relevant levels of adrenalin. In this
last case, the gH2AX expression increased very fast after its excision from the donor that an
immersion in DMEM could not prevent. These results underline the great necessity to take into
account excision techniques to collect biopsies to avoid unexpected artefacts.
P11—Withdrawn by the authors P12
Pilot study on the visualization of dermal injection of
hyaluronic acid by high-frequency ultrasound imaging, MRI,
and histology
G. Josse1, M. Haftek2, D. Gensanne3, V. Turlier1, A. Mas1, J. Theunis1, F. Ossant4, JM. Lagarde1,
AM. Schmitt1. 1Pierre Fabre Research Institute, Toulouse, 2University of Lyon I, EA 4169, Lyon,
3LCBM, CNRS FR 2599, Toulouse, and 4LUSSI, CNRS FRE 2448, Tours, France
In the past few years, increasing use of injectable resorbable fillings has been reported for
facial wrinkle treatment. However, the physiological processes involved, such as the localization
and subsequent diffusion of the injected product in skin tissues, are poorly documented. Efficacy
of hyaluronic acid (HA) injection is generally evaluated visually by the physician. This study
presents methods for non-invasive follow-up of the HA injection with regard to structural
information relating to tissue modifications. Three groups of 10 women had an intradermal
injection of HA in one arm and were assessed 1, 3, and 8 months after injection. The injection
was clearly visible by high-frequency ultrasound imaging and the dermis was significantly
swollen. By ultrasound signal analysis and parametric magnetic resonance imaging, a
macroscopic measurement of tissue modification over time was performed. In histological
sections, Alcian blue staining showed the presence of large pure exogene HA zones in the dermis.
Progressive dispersion of the HA deposit in the deeper part was observed over time. Moreover,
transmission electron microscopy analysis showed that, on the injected side, fibroblasts had an
‘‘activated’’ morphology. HA was apparently recycled by the activated cells.
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Effects of chondroitin sulfate on matrix metabolism and
inflammaging in H2O2-induced senescent fibroblasts and
keratinocytes
P. Bogdanowicz, M.-J. Haure, H. Hernandez-Pigeon, M. Charveron, N. Castex-Rizzi. Institut de
Recherche Pierre Fabre, Toulouse, France
The ability of human skin to rejuvenate diminishes with time, resulting in increased fragility,
which reflects a loss of connective tissue. Aging is also characterized by a chronic, low-grade
inflammatory status called inflammaging. Chondroitin sulfate (ACS) is a glycosaminoglycan,
which exerts anti-inflammatory and anabolic effects in articular cartilage, but little is known
about its properties in the dermis and epidermis. To evaluate ACS on skin aging, we have
developed an in vitro model of stress-induced premature senescence (SIPS), which is closely
related to chronological aging. We have evaluated the effects of ACS on matrix metalloprotei-
nases (MMPs), ILs, and collagen in SIPS fibroblasts and SIPS keratinocytes, and also the effect of
ACS on collagen synthesis in keratinocytes. By using quantitative reverse transcription-PCR, we
clearly showed that MMP-1 and MMP-3 are upregulated in SIPS fibroblasts and MMP-9 is
upregulated in SIPS keratinocytes. On the other hand, we observed a decrease in the type IVa1
collagen mRNA level in SIPS keratinocytes and an increase in both IL-6 and IL-8 cell types. We
have also shown that pre-incubation with ACS induced a strong inhibition of MMP (-1, -3, and -9),
IL-6, and IL-8, and an induction of type IVa1 collagen. On the other hand, we have also showed
in keratinocytes that ACS stimulated type IV collagen synthesis. Alterations of skin observed
during skin aging are because of modifications of dermal matrix loss, changes in the basal
membrane, and probably inflammation. Our findings illustrated the anti-aging properties of ACS
on those three different targets. ACS is able to reduce the exacerbated catabolic activity and
inflammaging, and to stimulate the anabolic activity in the epidermis, by stimulating type IV
collagen synthesis.
P14
Characterization of fibroblasts from wrinkles
F. Grandmottet, X. Luo, D. Binda, C. Viennet, P. Tiberghien, S. Robin, P. Humbert. Laboratoire
d’Inge´nierie et de Biologie Cutane´e, INSERM U645, Universite´ de Franche-Comte´, IFR 133,
Besanc¸on, France
Wrinkles are the earliest and most visible mark of skin aging. Wrinkle prevention and
correction are thus of major interest for dermo-cosmetic companies. Although skin aging
mechanisms have already been largely studied, only a few studies on fibroblasts isolated from
wrinkles have been performed. A cell bank containing fibroblasts from wrinkles and their controls
from nearby non-wrinkled skin was constituted to characterize cell specificities related to
wrinkles. Collagen I and matrix metalloproteinase-1 (MMP-1) have been measured by ELISA in
the supernatants of monolayer cell cultures. Biomechanical behavior of cells from wrinkles has
been evaluated using equivalent dermis, also called collagen lattices: the diameter of free lattices
was followed during 10 days, and intrinsic contractile forces developed by fibroblasts were
assessed in three-dimensional tensed lattices using the GLaSBox system.
Collagen 1 and MMP-1 synthesis by fibroblasts appear to be modified in wrinkles. Retraction
of free-floating lattices containing cells from wrinkles is diminished, which reflects alterations in
migration and extracellular matrix rearrangement abilities. Intrinsic forces developed by
fibroblasts from wrinkles are weaker than those of controls. These changes in cellular mechanical
properties could be responsible for tissular alterations, leading to wrinkle formation.
P15
In vitro study of keloid physiopathology
L. Lebcira, D. Binda, C. Viennet, P. Tiberghien, S. Robin, P. Humbert. Laboratoire d’Inge´nierie et
de Biologie Cutane´e, INSERM U645, Universite´ de Franche-Comte´, IFR 133, Besanc¸on, France
Keloids result from an excessive wound healing process involving an abnormal fibroblastic
activity, resulting in increased dermal tissue deposition. Our aim was to compare matrix
reorganization, cell proliferation, and myofibroblastic differentiation in fibroblasts isolated from
keloids (KFs) and neighboring healthy skin fibroblasts (NvFs). Antioxidant activities were further
assessed to understand the mechanisms of keloids formation. Cell growth was evaluated by cell
counting and total proteins measurement. Matrix reorganization was daily assessed by measuring
free lattice diameters for 10 days. Myofibroblastic differentiation was observed by a-smooth
muscle actin staining. Finally, oxidative stress was assessed by spectrophotometric measurement
of various parameters (reduced glutathione, glutathione reductase, and so on). KF proliferation
appears to be increased compared with NvFs, together with a higher lattice retraction. These
differences could be related to the observed changes of antioxidant activities. A better knowledge
of keloids’ cellular and molecular characteristics will allow more efficient prevention and
treatments.
P16
In vivo evaluation of PLA50-PEO-PLA50 scaffold as wound
dressing: angiogenesis and tissue integration
X. Garric1,2 J.-P. Mole`s2, D. Casellas3, J. Coudane1, M. Vert1. 1UMR5247, Faculty of Pharmacy,
2Laboratoire de Dermatologie Mole´culaire and 3GRH, Montpellier, France
Enhancing dermal tissue regeneration has significant implications for patients suffering from
large skin defects and chronic non-healing wounds. We recently developed synthetic dermal
substitutes from poly(a-hydroxy-acid)s that are bioresorbable polymers, and that present a great
variability of mechanical properties and hydrolytic degradation rates. These properties appear to
be of great interest in tissue engineering, including skin reconstruction. The aim of this study was
to evaluate the compatibility of a PLA50-PEO-PLA50 scaffold with the wound healing process.
Polymer scaffolds were implanted in nude mice according to two techniques: the first one
consisted in the implantation of porous scaffold in inguinal fold and the second technique
consisted in the engraftment of polymer scaffold on a mouse back to assess wound healing and
tissue integration. The evaluation of vascular colonization was obtained by immunostaining of
arteries and veins. After implantation in inguinal fold for a period of 28 days, we visualized a
vascular network composed of arterioles (stained with an antibody specifically directed against
smooth muscle cells) and veins detected with isolectin drip. We also studied the integration of
scaffold into a mouse back and we observed a very effective wound closing. This study thus
highlighted that a PLA50-PEO-PLA50 scaffold could be a support for in vivo angiogenesis and
tissue integration. It confirms that these types of scaffolds are good candidates for skin tissue
engineering and especially for help in wound healing.
P17
RhoB regulates the apoptotic response of UVB-exposed human
keratinocytes
B. Canguilhem1, A. Peyret-Lacombe1, A. Pradines1, N. Castex-Rizzi2, M. Charveron2, G. Favre1.
1INSERM U563; Institut Claudius Regaud; 2Institut de Recherche Pierre Fabre, Toulouse
UV irradiation generates many deleterious effects on skin tissue, leading to fast adaptive cell
response. Dysregulation of this response promotes premature photoaging and skin cancer.
Previous studies from our laboratory have shown that the small GTPase RhoB was strongly
upregulated after UVB exposure in HaCaT keratinocyte cell line. We have also shown that
inhibition of RhoB increased the UVB apoptotic response through its involvement in the EGFR
pathway. As immortalized HaCaT cells bear a mutated p53 and are more sensitive to apoptosis
than normal keratinocytes, we address herein the regulation of RhoB and the relationship
between RhoB and p53-apoptotic pathways in normal models, that is human skin explants and
epidermal keratinocytes primary cultures (normal human keratinocytes, NHK). We have first
shown that RhoB is upregulated in response to UVB exposure in human skin explants and in
NHK, independent of p53 expression. Moreover, we have shown that inhibition of RhoB
increases the UVB-induced apoptosis of NHK without any effect on p53 expression and activity.
In contrast, RhoB regulates Bcl-2 expression after UVB exposure through an AKT/Bad-mediated
pathway, independent of p53. These results put some light on RhoB as a protective determinant in
UVB cellular response and suggest its potential role in photocarcinogenesis. The identification of
RhoB-dependent molecular mechanisms would allow the development of new therapeutic
strategies in skin cancers.
P18
Effects of cysteine and vitamin B6 on doxorubicin-induced
apoptosis in human follicle dermal cells: relationships with
glutathione concentrations
C. Courderot-Masuyer1, S. Robin1,4, V. Weestel2, M. Di Palma3, P. Humbert4. 1Bioexigence et
2Service de Pneumologie, CHU Jean Minjoz, Besanc¸on; 3De´partement Plateau de consultations,
Institut Gustav Roussy, Villejuif, 4Service de Dermatologie, UMR645, IFR133, UFR Medecine-
Pharmacie, Besanc¸on, France
Alopecia is a common side effect of cancer chemotherapy. This study was undertaken to
investigate the potential effect of a mixture of cysteine and vitamin B6 on doxorubicin (DXR)-
induced apoptosis in human follicle dermal cells and also to follow the intracellular total
glutathione (GSH) concentration, a well-known antioxidant molecule. Human follicle dermal
papilla cells were pretreated for 3 days with cysteine, vitamin B6, or the mixture before adding
DXR. Apoptosis was evaluated using APOPercentage Apoptosis Assay. The intracellular
concentrations of GSH were measured by spectrophotometric detection in cellular homogenates.
The level of DXR-induced apoptosis was not modified by a pretreatment of cysteine or vitamin B6.
But the mixture (cysteineþ vitamin B6) decreased significantly this apoptosis. GSH concentrations
were higher after DXR administration, indicating the presence of an oxidative stress. After a
pretreatment by cysteine and vitamin B6, GSH concentrations were also increased. These
increases were related to the presence of cysteine because no change in GSH levels was observed
after a pretreatment by a single dose of vitamin B6. The beneficial effect of mixture
cysteineþ vitamin B6 was certainly because of the presence of cysteine, a precursor of GSH
and could avoid the appearance of chemotherapy-induced alopecia.
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Development of a skin substitute for therapeutic use, based on
human amnion
H. Tauzin1, C. Viennet1, A.-C. Goydadin1, D. Binda1, S. Robin1, P. Tiberghien2, P. Humbert1.
1Laboratoire d’Inge´nierie et Biologie Cutane´es, 2EFS Bourgogne Franche-Comte´, INSERM U645,
IFR133, Besanc¸on, France
Human amniotic membrane (HAM), derived from fetal membranes, is composed of three
layers, namely an epithelial layer, a basement membrane, and a nonvascular stroma containing
fibroblasts. It is a pool of growth factors, mitogenic and angiogenic factors, and cytokines, which
are known to act during wound healing, such as IL-6, IL-8, fibroblast growth factor, and EGF. A
clinical prospective study, carried out in Besanc¸on CHU, in collaboration with the French Blood
establishment of Bourgogne Franche-Comte´, showed that HAM is an excellent biological dressing
for leg ulcers treatment: Its application significantly enhances granulation tissue formation,
decreases fibrin clots, and improves wound healing. Our aim is to develop a new skin substitute
based on HAM, which could be a new therapeutic way for venous leg ulcers. Considering that
HAM epithelial cells are immunogenic by expressing CMH I antigens, experimentations are
realized with a de-epithelialized HAM by an enzymatic action. After de-epithelialization, it is
essential to verify basement membrane presence, using immunohistochemistry for collagen IV
and VII, and laminin 5. Later, autologous keratinocytes are seeded on the de-epithelialized HAM
and cultured for 21 days (first in emersion then at the air–liquid interface) to obtain a
reconstructed epidermis. Epidermic differentiation state characterization (histology and im-
munohistochemistry) is required to validate this new skin substitute. Validated de-epithelializa-
tion method is incubation with a 1.2 U ml1 dispase solution in phosphate-buffered saline for
30 minutes at room temperature. The basement membrane of de-epithelialized HAM is still intact
and is a good substrate for keratinocyte growth. The next important step is to obtain a fully
differentiated epidermis on de-epithelialized HAM.
P20
Halofuginone affects key fibroblast functions important for
tissue repair
C. Tacheau, L. Michel, D. Farge, A. Mauviel, F. Verrecchia. INSERM U697, Paris, France
Halofuginone, an alkaloid isolated from the plant Dichroa febrifuga, has been shown to be a
potent inhibitor of collagen synthesis both in vitro and in vivo. We aimed to clarify the effect of
halofuginone on fibroblast functions important for tissue repair. Incubation of human lung
fibroblasts with halofuginone led to dose- and time-dependent reduction of cell proliferation. At
concentrations 4107 M, halofuginone altered both proliferation and viability of fibroblasts, with
a potent arrest of the cell cycle in G2/M. In addition, these concentrations allow halofuginone to
reduce COL1A1 and COL1A2 expressions and neosynthesis through repression of their
promoters. At concentrations o107 M, halofuginone does not affect the cell cycle and was
found to induce rapidly extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal
kinase phosphorylation. Also at these low concentrations, halofuginone diminished the capacity
of fibroblasts to contract mechanically unloaded collagen lattices, and inhibited transformation
growth factor-b-driven collagen matrix contraction. The ERK inhibitor PD98059 inhibited
halofuginone effect on collagen lattice contraction by fibroblasts, suggesting that ERK pathway is
responsible for this effect. In conclusion, halofuginone, through distinct mechanisms, alters
fibroblast functions important for wound healing and implicated in the development of tissue
fibrosis, for example cell proliferation, collagen synthesis, and extracellular matrix contraction.
These properties may contribute to the therapeutic benefits of halofuginone observed in the
context of fibrotic disorders such as graft-versus-host disease or systemic sclerosis.
P21
Effects of physical and chemical treatments on biophysical
properties and micro-relief of human skin
N. Atrux-Tallau1, N.-T.-T. Huynh1, L. Gardette1, C. Pailler-Matte´i2, H. Zahouani2, E. Viviant3, H.
Hirsch3, M. Haftek1, F. Falson1, F. Pirot1. 1EA 4169 Fonctions Normales et Pathologiques de la
Barrie`re Cutane´e, University of Lyon 1 and 2Laboratoire de Tribologie et Dynamique des
Syste`mes, Ecole Centrale de Lyon, Lyon, France; 3Intuiskin SA groupe Memscap, Parc Activillage
des Fontaines Bernin, Crolles, France
The aim of this study was to determine the attendant effects of physical (tape-stripping) and
chemical (three commercial hydrating formulations) treatments on biophysical (transepidermal
water loss (TEWL) and hydration) and micro-relief properties of human skin. In the first set of
experiments, the effects of tape stripping on the human stratum corneum were assessed in nine
volunteers. In the second set of experiments, the effectiveness of three commercial ‘‘hydrating’’
formulations on biophysical parameters and micro-relief properties of acetone pretreated skin
were assessed in six volunteers after 2, 4, and 6 hours skin exposure. A linear relationship
between hydration and cutaneous parameters as function of the quantity of removed SC was
shown. Skin barrier properties (TEWL) were not modified by topical formulations. However, skin
treated by topical formulations showed slightly higher hydration than the control group, whereas
micro-relief parameters were not modified. In the tape-stripping experiment, we showed that
biophysical and micro-relief parameters were closely related. Efficiency of topical formulations
was suggested concerning skin hydration, but these treatments had no influence on the skin
micro-relief and barrier function recovery. From both experiments it appears that different
mechanisms may be involved in skin hydration and potential modification of cutaneous micro-
relief.
P22
Merkel cells proliferation and study of their neuroendocrine
properties in an enriched culture model
N. Boulais1,2, U. Pereira1, G. Dorange1, N. Rougier2, C. Chesne´2, L. Misery1. 1Facteur Nerveux et
Structuration Tissulaire, EA 4326-UBO, CHU Morvan, Bres; and 2BIOPREDIC International,
Rennes, France
Merkel cells (MCs) are of neural crest origin, they maintain synaptic contacts with sensory
neurons, and are capable of mechanotransduction. Besides these properties, MCs are also
neuroendocrine cells, which produce a wide array of neuropeptides and hormones. However, the
lack of a culture model impeded the study of their involvement in skin biology. We enriched
epidermal suspensions from piglet snouts in MCs by a magnetic cell sorting system. The presence
of numerous MCs was confirmed by immunocytochemistry and electron microscopy. In our
culture conditions, MCs could stay alive more than 4 weeks without nervous factors, they
extended cytoplasmic processes, and, surprisingly, we could detect proliferative MCs for the first
time. Then, in our culture model, we measured the release of vasoactive intestinal polypeptide
(VIP) from MCs. We show here that histamine, acetylcholine, or activation of the proton-gated/
osmoreceptor transient receptor potential vanilloid 4 modulated VIP release. Thus, this study was
the first to highlight the proliferative capacity of MCs, and also the modulation of their
neuroendocrine properties by biologically active molecules. These results suggested a putative
involvement of MCs in cutaneous pathophysiology, and maybe in skin sensitivity and
inflammation.
P23
Phenotypical characterization of Padi2 knockout mice
F. Coudane1, M.-C. Me´chin1, A. Huchenq1, V. Adoue1, A. Ishigami2, S. Chavanas1, C. Caubet1,
B. Werneburg3, G. Serre1, M. Simon1. 1UMR5165, CNRS-University of Toulouse III, Toulouse,
France; 2Meiji University, Tokyo, Japan; 3Boehringer Ingelheim Pharm., Inc., Ridgefield,
Connecticut, USA
Deimination or citrullination is a post-transcriptional modification catalyzed by peptidy-
larginine deiminases (PADs) that convert protein-bound arginines into citrullines. Three PAD
isoforms are expressed in the epidermis, namely PAD1, PAD2, and PAD3. PAD1 and PAD3 are
involved in the deimination of filaggrin, leading to the production of the natural moisturizing
factor. The function of PAD2 remains unknown. Pad2-deficient mice were generated by replacing
the first exon of the Padi2 gene with a Lac Z/neomycin cassette, and we analyzed their cutaneous
phenotype. The absence of Padi2 mRNAs and Pad2 protein was confirmed by western blotting
and reverse transcription-PCR experiments. No morphological or histological modifications in the
skin have been detected so far. The level of citrullinated proteins was not altered and no
detectable increase in the expression of the other Pad isoforms was observed. When analyzed by
immunohistology and western blotting, no change in the expression of the differentiation markers
such as keratin K10, involucrin, loricrin, and filaggrin was noticed. In addition, the barrier
function, as revealed by TEWL measurement, remained the same. These results show that the
absence of Pad2 does not induce any modification in cornification. A possible implication of
Pad2 in wound healing and UVB response will be investigated.
P24
a-Tocopheryl phosphate protects human epidermal stem
keratinocytes from oxidative stress
E. Noblesse, S. Talbourdet, R. Kurfurst, S. Schnebert, M. Dumas. LVMH Recherche, Saint-Jean-de-
Braye, France
The epidermis is characterized by a constant renewal throughout life, a process governed in
the epidermal basal cell layer by stem keratinocytes (SK) with a high mitotic potential. SKs
generate transit-amplifying keratinocytes (TAK) also able to divide but a smaller number of times.
TAKs produced post-mitotic daughter cells, irreversibly committed to terminal differentiation and
migration to the suprabasal cell layers. The ability of SK and TAK to generate daughter cells was
investigated in vitro by their potential to form large and smaller colonies of cells, respectively,
when seeded at low density on growth-arrested 3T3 feeder layer in vitro. The protective effect of
a-tocopheryl phosphate (aTP), a well-known antioxidant, was investigated by treating or not
(control) SK and TAK cultures for 24 hours and then by 100mM oxygen peroxide for 15 minutes.
After 7 days in culture, colonies of cells were fixed and stained with 1% rhodamine and the
images were acquired by a Sony tri-CCD Camera. Clonogenic patterns were established by
counting the colonies as a function of their size by Visilog (Noesis, Saint Aubin, France) image
analysis software. H2O2 stress produces a significant decrease in the number of largest SK-derived
colonies and also of the smaller TAK-derived ones. With 1mg ml1 a-tocopheryl phosphate (aTP)
treatment, the number of largest SK-derived colonies was near the level of unstressed keratinocytes.
In the absence of H202 stress, no proper colony-inducing effect of aTP was observed on
keratinocytes. We conclude that a moderate oxidative stress can affect basal epidermal SK by
decreasing their clonogenic potential and that this adverse effect can be largely reduced by a
treatment with aTP, which appears as an efficient candidate able to protect SK from oxidative stress
for maintenance of epidermal homeostasis.
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Expression of aquaporin-9 and 10 in human keratinocytes
M. Boury-Jamot1, J. Daraspe1, E. Noblesse2, J.-H. Cauchard2, M. Dumas2, J.-M. Verbavatz1. 1Lab
of Membrane Trafic, IBITEC-S CEA-Saclay, CNRS URA2096 CEA-Saclay and LRA17V University
of Paris Sud-11, France; 2LVMH Recherche, France
The aquaporins (AQPs) are a family of transmembrane proteins forming water channels.
Some AQPs also exhibit glycerol and urea permeability. Skin is the limiting tissue of the body, and
within the skin the stratum corneum of the epidermis is the limiting barrier to water loss by
evaporation. Skin epidermis is permanently renewed by continuous keratinocytes proliferation
and differentiation. Keratinocytes proliferate in the basal layer and they differentiate in the stratum
spinosum and stratum granulosum as they stratify and migrate toward the skin surface. Here we
examined the expression of AQPs in keratinocytes during differentiation. As previously reported,
AQP3 is abundantly expressed in keratinocyte plasma membranes and AQP10 mRNA was
detected by reverse transcription-PCR in HaCaT, a human keratinocyte cell line. In total RNA
extract from human epidermis, AQP9 mRNA was also found. Because of the high level of AQP9
detected, we postulated that AQP9 is expressed in keratinocytes. To test this hypothesis, we used
total RNA from reconstructed epidermis. Reconstructed epidermis is composed of differentiated
keratinocytes and exhibited only AQP3 and AQP9 mRNAs. By quantitative PCR, calcium-
induced differentiation resulted in an increase in AQP9 mRNA level, but not AQP3 or AQP10 in
normal human keratinocytes. Similar results were obtained by western blot experiments; AQP9
was overexpressed in HaCaT after calcium-induced differentiation. By indirect immunofluores-
cence, AQP9 is localized in the stratum granulosum of skin epidermis, where keratinocytes are
most differentiated. In conclusion, whereas AQP3 was found in both proliferative and
differentiated keratinocytes, AQP9 is expressed in differentiated keratinocytes and AQP10 in
proliferative keratinocytes only.
P26
Binding of a2ML1 to the low-density lipoprotein receptor-
related protein 1 reveals a new role for LRP1 in human
epidermis
M.-F. Galliano1, E. Toulza1, N. Jonca1, S. Gonias2, G. Serre1, M. Guerrin1. 1UMR5165 CNRS-
UPS, Toulouse, France. 2Department of Pathology, University of California San Diego, La Jolla,
California, USA
The multifunctional receptor low-density lipoprotein receptor-related protein 1 (LRP1) has
been shown to bind and internalize a large number of protein ligands with biological importance
such as the pan-protease inhibitor a2-macroglobulin (a2M). We recently identified a2ML1, a new
member of the a2M gene family, expressed in the epidermis. The expression of LRP1 in epidermis
as well as its ability to internalize a2ML1 was investigated. In human epidermis, LRP1 is
associated with the plasma membrane of the most differentiated keratinocytes, as shown by
immunohistochemistry using two different antibodies. In vitro, LRP1 moves from the cytosol to
the plasma membrane as proliferative keratinocytes are induced to differentiate. By using various
experimental approaches, we show that the receptor binding domain of a2ML1 (RBDl) is
specifically internalized into the macrophage-like cell line RAW and colocalizes with LRP1 upon
internalization. Co-immunoprecipitation assays indicate that RBDl binds LRP1 at the cell surface.
Addition of RAP, a universal inhibitor of ligand binding to LRP1, prevents RBDl binding at the cell
surface as well as internalization into RAW cells. Silencing Lrp1 expression with specific siRNA
strongly reduces RBDl internalization. Our study reveals that a2ML1 is a new ligand for LRP1.
These findings are consistent with endocytosis by LRP1 of complexes formed between a2ML1 and
proteases. LRP1 may thus control desquamation by regulating bioavailability of extracellular
proteases.
P27
Function of dermokine-secreted isoforms, new epidermal
proteins
L. Gazeilles, N. Jonca, E. Leclerc, E. Toulza, G. Serre, M. Guerrin-Weber. UMR5165 UDEAR
CNRS-UPS, Toulouse, France
The Dermokine gene (DMKN) was recently identified in our laboratory. It undergoes
complex alternative splicing leading to the production of four kinds of isoforms: d is intracellular
and ubiquitous, whereas a, b, and g are secreted and expressed only in epidermis. More precisely,
DMKN-b and DMKN-g are strongly expressed by granulous keratinocytes. Hence, they could
play an important role in the later steps of epidermis differentiation. Using yeast two-hybrid
system, we identified an interaction between Galectin-3 (Gal3), which is a ubiquitous and
pleiotropic lectin, and the glycine–serine-rich domain common to both DMKN-b and DMKN-g
isoforms. Immunohistochemical analysis of human skin shows a suprabasal and pericellular
localization of Gal-3, compatible with interaction of the lectin with DMKN-b and DMKN-g
isoforms. Interaction between recombinant DMKN and Gal-3 either recombinant or present in
epidermis protein extract was confirmed by GST pulldown assay. Preliminary results from solid-
phase binding assay show that the non-lectin domain of Gal-3 is the one implied in the
interaction. During skin wound healing in mice, DMKN-b and DMKN-g isoforms are strongly
expressed by numerous cell layers in the hyperproliferative epidermis. Moreover, expression is
concentrated at the cells’ apical poles, suggesting a function in barrier restoration. Gal-3
expression analysis and its colocalization with DMKN in those conditions are in progress. In spite
of the lack of information about Gal-3 function in epidermis, this study should enlighten
implication of DMKN-b and DMKN-g in late step of epidermis differentiation.
P28
Expression and localization of the ABCC membrane
transporters’ sub-family or MRP from primary culture of human
skin cells and epidermis
W. Khazen1, M. Dumas2, E. Noblesse2, 1J-M. Verbavatz1, M. Garrigos1. 1CEA, IBITECS, 2SB SM,
Gif-Sur-Yvette, France; 2LVMH Recherche—Parfum Christian Dior, Saint Jean-de-Braye, France
The nine MRP protein isoforms (multidrug resistance-associated proteins) constitute the
majority of the members of the sub-family C of membrane transporters, which possess an ATP-
binding consensus motif (ATP binding cassette). MRPs are generally involved in cellular
detoxification either by sequestering toxic molecules into various intracellular compartments or
by effluxing them out of the cell depending on their cellular location. We have characterized the
expression (by conventional and quantitative reverse transcription-PCR) of MRP1–7 mRNA as
well as their localization (by immunocytochemistry) in primary cultures of human keratinocyte or
melanocyte and in human epidermis. Keratinocyte and melanocyte cell lines show a similar
expression profile of MRP1, 4, 5, and 7 genes. In contrast, MRP3 expression is found only in
keratinocytes, whereas MRP2 expression is observed only in melanocytes. However, the MRP2
transporter was located in the perinuclear region of melanocytes, which preclude its use as a
polarity reporter in this cell line. To characterize the role of MRP2 in melanocytes, we try to
evidence its cellular functional activity using fluorescent transport substrates. The involvement of
MRPs in the cellular distribution of fluorescent molecules is shown using a specific MRP inhibitor
(MK571), whereas the contribution of MRP2 was validated by a siRNA approach designed to
selectively repress the expression of MRP2.
P29
Transdermal penetration of histamine by sonophoresis
A. Maruani1,2,3, E. Vierron1,4, M. Naouri1,3, M. Atlan1,5, B. Giraudeau1,4, L. Machet1,2,3, A.
Boucaud6. 1University Franc¸ois Rabelais of Tours; 2LUSSI CNRS-FRE 2448; CHRU Tours,
3Dermatology; 4INSERM CIC 202; 5Plastic surgery; 6Transderma Systems, Tours, France
Low-frequency ultrasound (US), called sonophoresis, has been used in animals and excised
human skin to investigate enhanced percutaneous absorption of drugs. We aimed to assess, in
healthy subjects, transdermal penetration of histamine by sonophoresis, in a double-blind
randomized controlled study. It was carried out in the Clinical Investigation Center of CHU Tours.
A total of 10 healthy subjects participated, and received on their right forearm US1 (2 seconds on/
5 seconds off, I1¼ 1.6 W cm2), US2 (3 seconds on/5 seconds off, I2¼ 2 W cm2), or no US. The
treatment of the zones was randomized. We used applied pulse-mode US at 36 kHz for 5 minutes.
After US application, a drop of histamine was deposited on each zone. The dermatologist, blinded
to the application of US, measured the area of the papule, which was the marker of transdermal
penetration of histamine, and controlled side effects. The treatment was discontinued in case of
necrosis. The results showed that 9/10 patients developed a papule with both US1 and US2. The
area medians (mm2) were 39.3 (12.6–121.0) for US1 and 62.8 (16.5–141.4) for US2. No papule
occurred when histamine was applied without US. Papules were meanly bigger with high
intensities of US, but this difference was not statistically significant (P¼ 0.527). No toxicity was
observed. This randomized controlled study shows the efficacy of sonophoresis in transdermal
penetration of histamine in humans. These results could be interesting for allergic tests, as
histamine prick tests, which involve skin disruption with a lancet before deposition of histamine,
are usually used as positive controls.
P30
Isolation of desmosomes from the human epidermis for research
on proteoglycans associated with these structures
Y. Sandjeu1, S. Callejon1, C. Vincent1, J. Guesnet2, A. Guezennec2, M. Haftek1. 1Universite´ Lyon
1, CNRS, Lyon, France; 2R&D YSL Beaute´, Neuilly-sur-Seine, France
Desmosomes (Ds) are multimolecular complexes essential for cohesion of keratinocytes in
human epidermis. They are constituted by two connecting cells, each contributing intracellular
plaque and transmembrane glycoproteins, which make the connection in the extracellular space.
KM48 antibody, produced in our laboratory, detects the presence of a proteoglycan molecule that
we have named desmosealin, associated with Ds. To study the presence of desmosealin and,
potentially, other proteoglycans in Ds, we have adapted a method to isolate these cell junctions
through the sequential steps of disintegration of keratinocytes and separation of the cell fractions
on discontinuous sucrose gradients. The content of various fractions was checked ultrastructurally
after inclusion in LR White resin and immunolabeling. Our results show that whole Ds structures
reactive to several antibodies detecting Ds molecules, such as desmoglein 1, can be enriched
from the human epidermis. The purification level of our Ds-enriched fraction differs from those
obtained by others from the bovine or amphibian skins. However, it appears sufficient to study the
presence of Ds-associated proteoglycans and to perform their biochemical characterization.
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Percutaneous absorption of organophosphorus compound using
in vitro pig and human excised skin
V. Vallet, G. Lallement, I. Boudry. De´partement de Toxicologie, Centre de Recherches du Service
de Sante´ des Arme´es (CRSSA), La Tronche, France
Organophosphates such as tabun (GA) are highly toxic compounds, which mainly penetrate
the body through percutaneous pathways. Thus, skin protection of people potentially exposed to
these agents is crucial. The development of effective protective formulations relies on a better
knowledge regarding the percutaneous penetration of such molecules. The purpose of this study
was to determine the in vitro percutaneous penetration parameters of GA using four in vitro
systems: full-thickness and split-thickness human abdominal and pig-ear skin membranes
mounted on static diffusion cells. A finite dose of GA was applied (5 mg cm2) in non-occlusive
conditions. The distribution of GA in the skin, reaching the receptor fluid or remaining non-
absorbed, was systematically determined after 24 hours. This study indicated that (a) taking into
account the higher permeability of pig skin to GA, the kinetic profiles of the percutaneous
penetration through human and pig in vitro models were similar; (b) the GA was mainly degraded
(more than 99%) during the percutaneous process; and (c) only a very slight fraction of GA was
recovered in the receptor fluid (o1% of the applied dose).
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Quality of clinical trials in dermatology: comparative
evaluation 1997–2006
F. Alvarez, N. Meyer, C. Paul. Dermatologie, CHU Toulouse and University Paul Sabatier,
Toulouse, France
Treatment choices are based on the results of randomized clinical trials (RCT). The
occurrence of bias and the poor quality of publications have been underlined (Adetugbo K and
Williams H, 2000). The Consolidated Standards for Reporting Trial (CONSORT) recommenda-
tions were made in 1996, revised in 2001, and adopted by the Journal of the American Academy
of Dermatology (JAAD) in 1999 and the British Journal of Dermatology (BJD) in 2000. We
assessed the influence of these recommendations on the quality of RCT. We selected RCT
published in the BJD and JAAD (years 1997 and 2006). The following criteria were evaluated:
control, blinding, mono- or multicenter, randomization, primary end point, power calculation,
type of funding, intent-to-treat analysis, sample size, and validity of statistical analysis. A total of
98 articles were identified (45 in 1997 and 53 in 2006). The comparison showed a significant
increase in the description of randomization’s method (20 vs 45%, Po0.01), in the description of
the primary end point (44 vs 64%, P¼ 0.05), and in the power calculation (22 vs 43%, P¼ 0.02);
on the contrary, the number of multicentric studies had decreased (60 vs 39%, P¼ 0.04). Despite
the adoption of CONSORT recommendations and a trend toward an improvement, the
methodological quality of dermatological clinical trials in therapeutic remains very insufficient.
Reference: Adetugbo K, Williams H (2000) How well are randomized controlled trials
reported in the dermatology literature? Arch Dermatol 136: 381–85.
P33
Melanoma in predisposed dog breeds: a spontaneous model to
identify the genetic causes of human melanoma
M. Gillard1, J. Abadie2, A. Primot1, P. Devauchelle3, M.-O. Semin4, L. Herbin1, C. Soyer3, F.
Galibert1, M.-D. Galibert1, C. Andre´1. 1Institut de Ge´ne´tique et De´veloppement, UMR6061
CNRS-University of Rennes1, Rennes; 2Unite´ d’Anatomie Pathologique, UMR707 IECM, Ecole
Nationale Ve´te´rinaire, Nantes; 3Centre Anticance´reux Ve´te´rinaire, Ecole Nationale Ve´te´rinaire
d’Alfort, Maisons Alfort; 4Laboratoire d’Anatomie Pathologique Ve´te´rinaire du Sud-Ouest,
LAPVSO, Blagnac, France
The interest in dogs, to unravel the genetic bases of human and dog complex diseases, such
as cancer, is because of their unique genetic structure, with a species split into 350 breeds as
genetic isolates. Furthermore, dogs share a common environment with humans and specific dog
breeds display high predisposition of specific cancers. Many dog breeds can thus be considered as
unique spontaneous models of specific cancer types. In humans, melanoma is a cancer of
increasing importance for public health, being the third most common cancer in women. The
incidence of this mostly malignant condition has doubled in the last 10 years and no efficient
therapy currently exists. Few genes, such as P16, PTEN, or B-Raf, have been identified as being
associated with the disease; however, there is an urgent need to identify prognostic tools and new
predisposing genes to improve early detection, diagnosis, and treatment follow-up. In dogs,
melanoma can be observed in all breeds, but certain breeds are at high risk and present different
melanoma types, malignancy, and metastatic profiles. To determine their genetic causes, we
collected blood and tumor tissue samples of three breeds (cases and controls), with the aim to
genotype 100 cases and 100 controls dogs of each breed with the recently available canine
127,000 SNP chip. In parallel, RNA profiling will be performed on all samples in order to identify
differential expression between the various melanomas.
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Search of the genetic causes of naso-plantar keratoderma in the
Dogue de Bordeaux, a spontaneous model for human
keratoderma
E. Guague`re1, S. Ku¨ry2, A. Thomas3, E. Bensignor4 M. Heuze´2, F. Degorce-Rubiales5, D.
Delattre3, F. Galibert2, G. Queney3, C. Andre´2. 1Clinique Ve´te´rinaire, Lomme, France; 2Institut de
Ge´ne´tique et De´veloppement, UMR6061 CNRS-Universite´ de Rennes1, Rennes, France;
3ANTAGENE 5Laboratoire de Ge´ne´tique Animaleb Limonest, France; 4Clinique Ve´te´rinaire,
Cesson-Sevigne´, France; 5Laboratoire d’Anatomie Pathologique Ve´te´rinaire du Sud-Ouest,
Blagnac, France
The interest in dogs, to unravel the genetic bases of human and dog-inherited diseases, is its
unique genetic structure, with a species split into 350 breeds, as genetic isolates. As each dog
breed can be considered as a unique spontaneous model of a given human disease, we believe
that the identification of the genetic alteration leading to this hyperkeratosis in Dogue de
Bordeaux will shed light on the genetics and pathophysiology of homologous human conditions.
Naso-plantar keratoderma (NPK), a hereditary cornification disorder affecting footpads and
eventually nose, has been reported in Irish terriers and Dogues de Bordeaux. To determine the
molecular causes of NPK in the Dogue de Bordeaux, we first estimated the prevalence to B5%,
without sex predilection and a mean age of onset around 18 months. Dermatological signs were
characterized by thickening with severe keratinous proliferations. Skin biopsies revealed severe
epidermal hyperplasia, diffuse and papillated orthokeratotic hyperkeratosis, and hypergranulosis.
We designed a genetic linkage study, based on a pedigree of 200 related dogs, including 40
affected dogs. Analysis of the pedigree led us to hypothesize a monogenic autosomal-recessive
mode of inheritance. A dozen of skin lesions have been collected for RNA extraction and
transcriptomic analyses. A whole genome scan, using the available canine 127,000 SNP chip is
ongoing.
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Search of the genetic causes of ichthyosis in the Golden
Retriever, a spontaneous model for human ichthyosis
E. Guague`re1, S. Ku¨ry2, E. Bensignor3, E. Que´nerch’Du2, F. Degorce-Rubiales4, L. Herbin2, A.
Muller1, J. Fontaine5, F. Galibert1, C. Andre´2. 1Clinique Ve´te´rinaire, Lomme, France; 2Institut de
Ge´ne´tique et De´veloppement, UMR6061 CNRS-Universite´ de Rennes1, Rennes, France;
3Clinique Ve´te´rinaire, Cesson-Sevigne´, France; 4Laboratoire d’Anatomie Pathologique Ve´te´rinaire
du Sud-Ouest, Blagnac, France; 5Clinique ve´te´rinaire, Bruxelles, Belgium
The interest in dogs, to unravel the genetic bases of human and dog-inherited diseases, is its
unique genetic structure, with a species split into 350 breeds, as genetic isolates. As each dog
breed can be considered as a unique spontaneous model of a given human disease, we believe
that identification of the genetic alteration leading to ichthyosis in the Golden retriever might shed
light on the genetics and pathophysiology of human non-epidermolytic forms of ichthyosis. The
disease in dog is characterized by a mild-to-severe generalized scaling, initially with small
whitish scales, progressively becoming blackish. Histological features show moderate-to-severe
laminated or compact orthokeratotic epidermal hyperkeratosis, with no proliferation of
keratinocytes. Ultrastructural findings revealed numerous persistent corneodesmosomes within
the stratum corneum. To determine the molecular causes of ichthyosis, we collected 150 blood
samples of Golden retriever, including 73 affected. There is no sex predilection and a mean age of
onset comprised between 3 weeks and 3 years. A genetic study, based on a pedigree of 150
related dogs, including 30 affected, allowed us to hypothesize a monogenic autosomal-recessive
mode of inheritance, and genotyping using the available canine 127,000 SNP chip is ongoing.
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Myrtacine regulates arachidonic acid cascade, cyclooxygenase,
and lipoxygenase pathways in human keratinocytes: interest in
the treatment of inflammatory acne disease
M.-F. Aries1, G. Chene2, B. Pipy2, N. Castex-Rizzi1, M. Charveron1. 1Pierre FABRE Research
Institute and 2INSERM IFR31, Toulouse, France
Acne vulgaris is an exceptionally common, chronic, and recurring disorder affecting many
adolescents and adults throughout their lifetimes. The pathogenesis of acne is multifactorial and is
thought to involve excess sebum, follicular hyperkeratinization, bacterial colonization, and
inflammation. Many therapeutic options exist for treatment of acne, including topical or systemic
drugs. These drugs exert their therapeutic effects by not only bacteriocidal actions but also anti-
inflammatory actions. Drugs possessing these anti-inflammatory capacities are clinically
beneficial for treatment of inflammatory acne. As in inflammatory skin disorders dysregulation
of epidermal eicosanoids biosynthesis is also observed, we focused on these inflammatory potent
mediators that represent an heterogeneous family derived from arachidonic acid (AA) metabolism
by cyclooxygenase (prostaglandins) and lipooxygenase (leukotrienes) pathways. The aim of this
study was to investigate the activity of Myrtacine, a new extract of Myrtus communis aerial parts
containing 1% myrtucommulones, on the AA metabolism of human keratinocyte cell line HaCaT.
The Myrtacine (1, 3, and 10 mg ml1) was found to inhibit the A23187-triggered increase in the
levels of [3H]-labeled metabolites of the cyclooxygenase (81 to 100%) and 5-lipoxygenase
(52 to 95%) pathways. A closer examination of the activity of Myrtacine on 6KPGF1a, PGF2a,
PGE2, PGD2, PGA2, LTB4, and HETEs revealed the dose-dependent inhibition of each AA
metabolite. This activity could be associated with a new AA distribution at the membrane lipids
level. Our results indicate the strong regulator properties of Myrtacine with respect to cutaneous
inflammatory response showing therefore a real interest of Myrtacine in the treatment of acne.
www.jidonline.org 805
ABSTRACTS
P37
Development of an experimental model of itch using histamine
iontophoresis in healthy subjects
L. Bergeret1, D. Black2, J. Theunis2, P. Celsis1. 1Inserm U825, Hoˆpital Purpan, Toulouse, France;
2Centre de Recherche sur la Peau, IRPF, Toulouse, France
In experimental studies on itch, the mode of induction employed often uses intradermal
histamine injection (prick test). However, the use of iontophoresis for histamine delivery could
allow for better control of the intensity and duration of the itch sensation. This approach has been
validated on a study involving 56 healthy subjects (28 males and 28 females, aged 18–35 years) to
determine the degree and variability of the perceived sensation. On each flexor aspect of the
forearm, two 0.8 cm2 sites had 50 ml of histamine chloride (10 mg ml1) applied for 16 seconds
using current of 0.24 mA (900 Hz). Itch intensity was assessed by the subject for 15 minutes using
a 10-cm visual analog scale. The results showed an overall low intensity of perceived itchp1 cm,
with a peak 4 minutes after induction, which decreased in a similar manner for the two groups. An
analysis of variance showed no significant difference between sexes. After 15 minutes, itch
intensity remained 40 for both groups, but was nonsignificant for male subjects compared with
pre-induction values. The order of histamine application on itch intensity was significant, with, in
decreasing order of intensity: 2nd 41st 44th 43rd. With regard to right/left application, no
significant differences were observed. In conclusion, the model of induction used shows no male/
female differences, and is able to rapidly produce a weak itch sensation, which peaks at
4 minutes. The order of application could vary the results. Using this model, it should be possible
to modulate itch intensity by varying the amount of histamine used, the amount of current, and its
application time.
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Is systemic sclerosis a laminopathy?
C. Gaudy-Marqueste1,2, J.-J. Grob1, N. Levy2, A.-C. De Sandre-Giovannoli2. 1Service de
dermatologie, Hoˆpital Sainte Marguerite, Marseille, France; 2Laboratoire de Ge´ne´tique
mole´culaire, Hoˆpital La Timone, Marseille, France
Lamins are proteins of the nuclear envelope involved in pathologies called ‘‘laminopathies.’’
As clinical similarities exist between systemic sclerosis and some laminopathies (for example,
Hutchinson–Gilford progeria and restrictive dermopathy), we hypothesized that systemic sclerosis
could be due to lamin mutations. Our purpose was to identify, in a cohort of 33 patients (13
systemic sclerosis, 11 CREST syndrom, 3 localized scleroderma, and 6 complex phenotypes) vs
controls, mutations in three genes involved in nuclear lamina constitution, namely LMNA,
encoding lamins A/C; FACE1, encoding a protease involved in lamin A processing; and LBR,
encoding the lamin B receptor. Molecular analyses were performed on DNA extracted from
peripheral blood. Denaturing high performance liquid chromotography multiplex ligation-
dependent probe amplification was used for detecting sequence variations, and sequencing for
variation characterization. Transcriptional analyses (reverse transcription-PCR) and MLPA
analysis were performed in some cases. A total of 24 sequence variations were identified (7 in
LMNA, 6 in FACE1, and 11 in LBR); of these 7 variations have never been reported, namely c.1-
46G4A, c.474þ 83A4c, and c.474þ 102T4C in FACE1; c.165þ74C4T, c.1071G4A,
c.1484-115C4T, and c.22A4C in LBR. Transcriptional analyses eliminate an impact on
splicing, whereas MLPA analysis showed no LMNA deletion or duplication. Our results suggest
that LMNA, ZMPSTE24, and LBR mutations are unlikely to be a major cause of systemic sclerosis,
and complementary analyses of other genes encoding LMNA partner’s proteins are, however,
necessary to formally exclude systemic sclerosis from the laminopathy nosologic spectrum.
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Anomalies leading to the mineralization of elastic fibers in
pseudoxanthoma elasticum and the PXE-like syndrome
Y. Le Corre1, L. Martin1, O. Vanakker2, L. Schurgers3, D. Gheduzzi4, C. Vermeer3, I. Pasquali-
Ronchetti4, P. Coucke2, A. de Paepe2. 1University of Angers, France; 2University of Ghent,
Belgium; 3University of Maastricht, The Netherlands; 4University of Modena, Italy
Pseudoxanthoma elasticum (PXE) is an inherited metabolic disease of connective tissues
characterized by the mineralization and fragmentation of elastic fibers. Classic PXE is linked to
the ABCC6 gene that encodes a membrane transporter in the liver. The link between this
transporter and distant elastic fiber changes is unknown. We recently described a PXE-like condi-
tion associated with deficiencies in clotting factors dependent on vitamin K and related to the
GGCX gene, which encodes a carboxylase active in the presence of vitamin K and allows the
activation of various inhibitors of mineralization (matrix Gla protein, osteocalcin). We show here
using specific antibodies against active or inactive species of inhibitors of mineralization that the
immunohistochemical profile is similar in both PXE conditions. On the contrary, plasma
measurement of the species of inhibitors of mineralization using ELISA assays is significantly
different in both conditions. These findings allow dissection of the steps leading to the final
mineralization in both conditions and stress the potential therapeutical role of vitamin K.
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High-resolution cutaneous ultrasonography in the differential
diagnosis of lipoedema and lymphoedema
M. Naouri, M. Samimi, C. Vallin, A. Maruani, L. Vaillant, L. Machet. Universite´ Franc¸ois Rabelais
de Tours, Service de Dermatologie, CHRU de Tours, Tours, France
Lipoedema (LP) is an accumulation of fat abnormally distributed in the lower limbs without
edema. Differential diagnosis between LP and lymphoedema (LY) is clinically difficult. High-
resolution ultrasonography (HRU) helps in detecting dermal edema. We thus put forth the
assumption of different aspects regarding LP and LY. A total of 16 LP, 21 LY, and 16 controls were
included. HRU was carried out on three different sites for each leg, namely thigh, leg, and ankle.
Images were then anonymized and examined by a dermatologist who was blind from clinical
diagnosis. Dermal hypoechogenicity was evidenced in 12 thighs (57%), 18 legs (85%), and 20
ankles (95%) in LY. HRU was normal in all controls and LP, except one (12.5%) with dermal
hypoechogenicity at the ankle site only. Average dermal thickness were 2.2 mm (SD¼ 0.6) on
thighs, 2.8 mm (SD¼ 0.6) on legs, and 3.0 mm (SD¼ 0.7) on ankles in LY; 1.5 mm (SD¼0.3) in
thighs, 1.6 mm (SD¼ 0.3) on legs, and 1.5 mm (SD¼ 0.3) on ankles in LP; and 1.5 mm (SD¼ 0.2),
on thighs, 1.4 (SD¼ 0.3) on legs, and 1.4 (SD¼0.2) on ankles in controls. HRU makes it possible
to differentiate LY from LP. A significant increase in dermal thickness and a marked dermal
hypoechogenicity were characteristic of LY. In LP, dermal echogenicity and thickness were
normal. Infraclinic venous insufficiency may explain the case with ankle edema and LP. HRU is a
useful tool that can help in diagnosis of LP and avoid useless lymphatic drainages and provide
adequate counseling and diet.
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Studies of the pattern of sphingolipids in the stratum corneum
of the atopic dog
I. Popa1, N. Remoue1, B. Colsch2, D. Pin3, M. Haftek1, J. Portoukalian1. 1Laboratoire de
Recherche Dermatologique, EA4169 University of Lyon-1, Hospital Edouard Herriot, Lyon,
France; 2Laboratoire de Neurochimie, Hospital de la Salpeˆtrie`re, Paris, France; 3Ecole Ve´te´rinaire
de Lyon, Lyon, France
The major role of ceramides in the skin is to maintain the epidermal barrier protecting the
body against harmful agents and water loss. In several skin diseases such as atopic dermatitis
(AD), the lamellar lipids of the stratum corneum are disorganized and some species of ceramides
are missing compare with those of healthy dog skin. A total of 12 tape strips were taken from the
thorax of one normal dog and one AD dog. The epidermal-free lipids were extracted from the
strips, and then the protein-bound lipids were released by alkaline treatment. The lipids were
separated into different classes and analyzed by thin-layer chromatography. The patterns of
ceramides, neutral glycosphingolipids, and gangliosides were determined. In the strips from the
normal dog skin, the ceramide pattern was almost similar to the one reported in human skin. The
content of free ceramides was low in strips 1–4, higher in strips 5–10, and then decreased in strips
11 and 12. The glucosylceramide content was high in all strips. Regarding the protein-bound
lipids, high amounts of ceramides A and B were seen in all strips, but no glucosylceramide. Traces
of GM3 and GM1 gangliosides were found in all strips and a larger amount of GM1 was
noticeable in strips 9 and 10. In an uninvolved area of AD dog skin, free ceramides and
glucosylceramides were present in all strips that also contained traces of gangliosides, but the
distribution of protein-bound sphingolipids was very different. Ceramide A and glucosylceramide
were present in all strips. Several unidentified spots of protein-bound ceramides are currently
analyzed by mass spectrometry.
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Incidence of autoimmune pemphigus in the Midi-Pyre´ne´es
Region: epidemiological study
M. Thomas1, C. Paul1, F. Fortenfant2, J. Mazereeuw-Hautier1, S. Prey1, C. Livideanu1, A.
Ammoury1, R. Viraben1, N. Meyer1. 1Dermatology, 2Immunology, CHU Toulouse and University
Paul Sabatier, Toulouse, France
The epidemiology of autoimmune pemphigus (AIP) in Western Europe is poorly known: two
studies have evaluated its incidence at 1.7 106 case per year (Paris and surrounded region,
1985–1990) and at 0.7 106 (England, 1996–2006), respectively. We performed a retrospective
study of the annual incidence of AIP in the Midi-Pyre´ne´es Region (MPR), between 2002 and
2006. Cases were detected using skin direct immunostaining (DIS) database of all MPR
laboratories, and confirmed by the dermatologists. Diagnosis of AIP was considered if the patient
had been living in the MPR during the first diagnosis of positive DIS and had presented blisters
and/or erosions cutaneous and/or mucosal, authentified by a dermatologist. Demographic and
environmental data were collected. From 2002 to 2006, 37 cases fulfilled the criteria,
corresponding to an annual incidence of 2.9 106 cases. For 28 cases, environmental data
were available and 4 facts were remarkable, namely meridional origin (excepted France) 20%;
personal history of cancer 22%; non-smoker 82%; and risk of occupational exposure to toxics
43%. The incidence of AIP in the MPR seems to be increased. Meridional origins and
occupational exposure to toxics could be a facilitating condition.
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Detection of a- and b-human papillomavirus in cutaneous
melanoma: a matched and controlled study using specific
multiplex PCR combined with DNA microarray primer
extension
J.-B. Ruer1, T. Gheit2, L. Pe´pin1, C. Vidal3, M. Tommasino2, J.-L. Pre´tet1, C. Mougin1, F. Aubin1.
1University of Franche-Comte´, EA3181, IFR133, Besanc¸on, France; 2IARC, Lyon, France; 3Centre
d’Investigations Cliniques, CHU de Besanc¸on, Besanc¸on, France
There are few contradictory studies investigating the involvement of human papillomavirus
(HPV) in melanoma. We designed a controlled study to evaluate the HPV DNA prevalence in
melanoma. A total of 100 patients with cutaneous malignant melanoma diagnosed between 2002
and 2006 were included. Complementary-wide excision (healthy skin) was performed in 85
patients and was used as internal control. After DNA extraction, 68 different HPV types were
studied using a multiplex PCR combined with microarray primer extension. We did not observe
any statistically significant difference in terms of HPV DNA prevalence in melanoma (38.8%) and
in healthy skin (HS) from wide excision (42.4%). Overall 21 different HPV types were detected,
but only 1 type was present in the majority of our samples (80/85 melanoma vs 59/66 HS). The
distribution of HPV genera and types was similar in melanoma and HS, and b-HPV was
predominant (30.6 and 31.8%). Among a-HPV (10.5 and 10.6%), HPV16 was predominant. No
correlation between clinical and pathological melanoma characteristics and HPV DNA
prevalence was found. This is the first study investigating the HPV DNA prevalence in a large
series of melanoma matched with healthy skin from same patient. Our results confirm previous
data, suggesting that HPV DNA is widely distributed among the population and that occult HPV
infection is frequent. In addition, we do not confirm the role of HPV infection in melanoma.
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E6 and E7 from different b-HPV do not interfere UVB-induced
apoptosis in HaCaT cells
J.-S. Guerrini1, V. Bouvard2, E. Oswald3, A. Alonso3, M. Tommasino2, C. Mougin1, F. Aubin1.
1University of Franche-Comte´, EA 3181, IFR133, Besanc¸on, France; 2IARC, Lyon, France; 3DKFZ,
Heidelberg, Germany
UV is the most important factor implied in the development of non-melanoma skin cancer
(NMSC). Apoptotic elimination of UV-damaged cells from the epidermis is the major step in
preventing both emergence and expansion of cells with carcinogenic potential. Human
papillomaviruses (HPVs) have been implicated as a cofactor in the development of NMSC, but
the functional role of UV irradiation in combination with the E6 and E7 proteins of the b-HPV
types has not been elucidated. Here, we investigated the role of E6 and E7, the two major viral
oncoproteins, on UVB-induced apoptosis in HaCaT cell line. The high-risk b-HPVs used have
been chosen for their ability to expand the lifespan of primary human keratinocytes. HaCaT cells
have been transduced with E6/E7 from these b-HPVs using a retroviral system. After UVB
exposure, cytometry analyses have been conducted and apoptotic level has been studied. We did
not observe any difference in apoptosis between cells expressing E6 and E7 and control cells
according to the dose of UVB or the time after exposure. As p53 has been described as a key
protein in E6 and E7 effects of HPV38, we restored p53 activity in the p53-mutated HaCaT cells,
using PRIMA-1 (p53 reactivation and induction of massive apoptosis) or transduction of a wild-
type p53 with a retroviral system. These experiments did not affect UVB-induced apoptosis
neither in E6/E7-transduced cells nor in control cells. These data suggest that these two viral
oncoproteins have no effect on UVB-induced apoptosis of HaCaT cells.
P45
Rare skin cancer: a population-based cancer registry descriptive
study of 151 consecutive cases diagnosed between 1980 and
2004
M.-O. Riou1, E. Fournier2, A. Danzon2, F. Pelletier1, P. Humbert1, F. Aubin1,3. University of
Franche Comte´ 1Department of Dermatology; 2Registre des Tumeurs du Doubs, CHU de
Besanc¸on, EA2276, IFR133, re´seau FRANCIM, 3EA3181, IFR133, Besanc¸on, France
There are few epidemiological data available on rare skin cancer, including Merkel cell
carcinoma, Paget’s disease, adnexal carcinoma, and sarcoma. We conducted this study to
investigate the epidemiological and clinical features of rare skin cancer diagnosed in the
Department of Dermatology of Doubs from 1980 to 2004. Data were collected from the Doubs
Cancer Registry from 1980 to 2004. Diagnosis was based on the third edition of the International
Classification of Diseases for Oncology. The incidence rates were standardized on the world
population. A total of 151 patients were investigated (88 females and 63 males). Median age for
the diagnosed disease was 63 years. The standardized incidence rate was 0.82/100,000 person-
year (95% CI¼ 0.68–0.96) and increased from 0.25 in 1980–1984 to 1.50 in 2000–2004. In total,
59 cases (39%) were sarcomas, 35 (23%) adnexal carcinomas, 27 (18%) Merkel cell disease, and
27 (18%) Paget’s disease. The standardized incidence rates were 0.37/100,000 (0.27–0.47) for
sarcomas, 0.16 (0.10–0.22) for adnexal tumors, 0.13 (0.08–0.18) for Merkel carcinoma, and 0.15
(0.09–0.21) for Paget’s disease. This study, based on an exhaustive patient list from a population-
based cancer registry and not from a hospital series, showed an increase in the standardized
incidence rate for all types of rare skin tumors. It is remarkable to note that these supposed rare
skin cancers are not so rare when compared with the standardized incidence rate of mycosis
fungoides (0.2/100,000 person-year over the same period from the same database).
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Constitutive activation of NF-jB in cutaneous T-cell lymphoma:
involvement of TCR pathway
J. Baraut, F. Jean Louis, J. Gautheron, F. Verrecchia, H. Bachelez, G. Courtois, L. Michel. INSERM
U697, Service de Dermatologie 1, Hospital Saint-Louis AP-HP, Paris, France
Our recent study indicates that tumor cells from cutaneous T-cell lymphoma (CTCL) exhibit
constitutive activation of the classical NF-kB pathway that is involved in resistance to apoptosis
(Sors et al., Blood, 2006). However, the origin of this constitutive activation remains unknown.
One hypothesis is deregulation of the T-cell receptor (TCR) pathway and the aim of our study is to
target altered molecular events in this pathway. CTCL cell lines (HuT-78, SeAx, and MyLa) were
co-transfected with negative-dominant molecules, specific for the TCR-linked NF-kB pathway,
and a plasmid reporter Igk-luc that measures the NF-kB activation level. Transfection with
negative dominants for Bcl10 or PKCy, as well as transfection of specific PKCy siRNA, inhibited
NF-kB transcriptional activity in a dose-dependent manner. This result indicates that the pathway
is not deregulated downstream of CARMA1–Bcl10–MALT1 complex, but at the level of this
complex and of PKCy. Addition of a specific inhibitor of PKCy, rottlerin, after Igk-luc transfection,
decreased luciferase activity. Rottlerin (1.56–50 mM) also inhibited NF-kB transcription activity, as
shown by electrophoretic mobility shift assay and immunocytochemistry (dose-dependant
inhibition of p65 NF-kB nuclear staining). Moreover, this inhibitor induces apoptosis of CTCL cell
lines and tumor cells from patients with Se´zary syndrome, as shown by the increase in the number
of annexin Vþ /propidium iodideþ , decrease in mitochondrial transmembrane potential,
procaspase 3 activation, and PARP cleavage. Therefore, NF-kB constitutive activation in CTCL
is associated with a molecular deregulation at CARMA1–Bcl10–MALT1 complex and PKCy level
in TCR pathway, offering new potential therapeutic targets.
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Toll-like receptors 2, 4, 7, and 9 expression in CD30þ
cutaneous T-cell lymphoma
A.-C. Knol1, A. Dompmartin5, G. Que´reux2,1, F. Comoz4, J.-J. Renaud3, A. Khammari2,1, B.
Dre´no2,1. 1INSERM U892, 2Clinique dermatologique, CHU Hoˆtel-Dieu, and 3Institut d’histo-
pathologie, Nantes, France; 4Service d’anatomie Pathologique, and 5Clinique Dermatologique,
CHU Coˆte de Nacre, Caen, France
CD30þ anaplastic large cell lymphoma is a primary cutaneous lymphoproliferative disorder
with a high rate of spontaneous regression (B25%) whose pathogenesis remains unclear, making
the association with viruses suspected. The aim of this study was to assess Toll-like receptor (TLR)-
2, -4, -7, and -9 expressions in cutaneous biopsies from patients with CD30þ anaplastic large
cell lymphoma and type C lymphomatoid papulosis. Immunohistochemical analysis of TLR-2, -4,
-7, and -9 expressions was conducted on paraffin-embedded sections of cutaneous biopsies
obtained from 12 patients with CD30þ T-cell lymphoma (n¼ 9) and type C lymphomatoid
papulosis (n¼ 3). Five healthy skins were used as controls. We observed that TLR-2, TLR-4, and
TLR-7 were weakly expressed in the epidermis of each normal skin, whereas no immunoreactivity
was detected for TLR-9. In cutaneous lesions of CD30þ T-cell lymphoma and type C
lymphomatoid papulosis, we observed a moderate (42%)-to-strong (33%) intensity of labeling
with TLR-2, TLR-4 (moderate: 50% to strong: 25%), and TLR-7 (moderate: 33% to strong: 42%) in
the epidermis, and in 25% of cases, we detected an expression of TLR-7 within the lymphocytic
infiltrate. In TLR-9, we observed a weak (25%)-to-moderate (25%) expression in the epidermis.
The development of cutaneous lesions in CD30þ T-cell lymphoma appears to be associated with
an increased expression of TLR-2, -4, -7, and -9 by keratinocytes and of TLR-7 by T lymphocytes,
perhaps induced by a virus, and thus contributing to the maintenance of the lymphocytic infiltrate
in cutaneous lesions.
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Stable overexpression of Connexin43 in human melanoma cells
inhibits their tumorigenicity in vitro
J. Loy, L. Puaud, C. Tacheau, A. Mauviel, F. Verrecchia. INSERM U697, Paris, France
Reduced or loss of gap junctional activity, usually associated with a decrease in connexin
expression, has been implicated in various human cancers such as malignant melanoma.
Preliminary evidence indicates that connexine43 (Cx43) may be a tumor suppressor in malignant
melanoma. In this context, we investigated the effect of Cx43 overexpression on melanoma cell
behavior. Using the highly metastatic cell line, 1205-Lu, we generated melanoma cell clones
constitutively expressing Cx43, and their mock-transfected counterparts. Stable expression of
Cx43 resulted in an increase in gap junctional intercellular communication between melanoma
cells, as measured using scrape-loading experiments. Cx43 overexpression decreased their
proliferative capacity while not affecting their adhesion to collagen and laminin. On the other
hand, overexpression of Cx43 efficiently reduced the capacity of human melanoma cells to
migrate and to invade Matrigel in Boyden migration. Cx43-overexpressing melanoma cells
exhibited a dramatically reduced capacity to form colonies under anchorage-independent culture
conditions. These results indicate that Cx43 expression by melanoma cells affects the tumor
environment and directly contributes to tumor cell aggressiveness.
www.jidonline.org 807
ABSTRACTS
P49
A novel mutation of CGI-58 in an Indian patient with
Dorfman–Chanarin syndrome
N. Bouzaiene1, P. Schischmanoff2, R. Kumar3, Z. Ben Selma1, A. Blom4, L. Laroche4, F. Caux1,4.
1INSERM ERI18, University Paris XIII; 2Biochemistry and 4Dermatology, CHU Avicenne,
Bobigny, France; 3Dermatology, Jagjivan Ram Hospital, Mumbai, India
Dorfman–Chanarin syndrome (DCS) is an autosomal-recessive disease characterized by
congenital ichthyosiform erythroderma and systemic accumulation of triglycerides. Germline
mutations of CGI-58 gene encoding an activator of a new lipase, ATGL, are associated with this
disease. Here we reported the first study of CGI-58 in the Indian population and described a new
mutation of this gene in an Indian patient with DCS. A child from Mumbai presented with a
typical DCS. Cutaneous electron microscopy revealed lipid droplet devoid of membranes in
keratinocytes. Both parents and his brother were phenotypically normal. Genomic DNA was
extracted from the patient’s and relatives’ blood and the seven exons of CGI-58 gene were
sequenced. A homozygous A insertion in exon 5 after position 730 was shown. This insertion was
observed at a heterozygous state in both parents but was absent in the brother. This variant
induces a reading frame shift and a premature stop codon, resulting in a shortening of the protein
(252 amino acids instead of 349) with nine C-ter missense amino acids. To determine whether this
nucleotide variation alters splicing of mRNA, we performed in silico splicing analysis, which
predicted no abnormal splicing. This 730insA variant is probably deleterious because the
functional activity of the CGI-58 protein is very sensitive to structural modifications as shown
previously. In conclusion, we reported an original 730insA mutation in an Indian family, which
results in a truncated CGI-58 with a probable loss of function of this protein.
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A novel germline mutation, Leu168Pro, of fumarate hydratase
in a patient with Reed’s syndrome and cerebral astrocytomas
F. Caux1, B. Bressac-de Paillerets2, A. Le´vy3, O. Zehou1, J. Bombled2, A. Blom1, L. Laroche1.
1INSERM ERI18, University Paris XIII, Paris, France; 1Dermatologie et 3Anatomopathologie, CHU
Avicenne, Bobigny, France; 2Ge´ne´tique, Institut Gustave Roussy, Villejuif, France
Reed’s syndrome is an autosomal-dominant disease characterized by multiple cutaneous and
uterine leiomyomatosis. Germline mutations of the fumarate hydratase (FH) gene encoding an
enzyme of the tri-carboxylic acid cycle and also acting as a tumor suppressor have been
associated with Reed’s syndrome in 2002. Here we reported a patient with this syndrome and a
new missense mutation of the FH gene. A Spanish woman presented with a history of several
cerebral astrocytomas, multiple skin leiomyomata, and uterine leiomyomatosis. Numerous
similar skin lesions were present in the patient’s mother, brothers, sisters, and son. DNA was
extracted from the patient’s blood and the 10 exons of FH were sequenced. A heterozygous T-to-
C transition in exon 5 at position 503 was identified. This 503T4C transition substituted leucine
for proline at position 168 (Leu168Pro). This variant 503T4C, which has not been reported
previously, was not detected in 100 normal subjects. Several data suggested that this Leu168Pro
mutation may have functional consequences: (i) it is located in the catalytic site of the enzyme
and (ii) FH amino-acid alignment showed that Leu168 is highly conserved among studied species.
This novel L168P mutation of fumarate hydratase probably is pathogenic and responsible of the
cutaneous and uterine leiomyomatosis of the patient, and also may be implicated in the
pathogenesis of her cerebral astrocytomas.
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Longe-range transcriptional control of the gene PADI3
S. Chavanas1, V. Adoue1, M.-C. Me´chin1, S. Ying2, S. Dong2, H. Duplan3, M. Charveron3, H.
Takahara2, G. Serre1, M. Simon1. 1UMR5165, CNRS-UPS, Toulouse, France; 2Ibaraki University,
Japan; 3CERPER, Toulouse, France
Peptidylarginine deiminases (PADs) catalyze the conversion of protein-bound arginine into
citrulline. This post-translational modification known as deimination is thought to be critical in
the metabolism of the epidermal barrier protein filaggrin. PAD3, specific for the most
differentiated epidermal keratinocytes, was shown to be involved in filaggrin deimination. The
mechanisms controlling the expression of its encoding gene, PADI3, are not known. We showed
earlier that the PADI3 promoter binds NFY and Sp1/3 factor as PADI4, which is not expressed in
the epidermis, suggesting a higher level of transcriptional control. We here describe the first PAD
intergenic enhancer (PIE1). PIE1 is an evolutionary-conserved non-coding segment located 80 kb
from the PADI3 promoter. Luciferase assays showed that it is a strong and DNAse I-hypersensitive
enhancer of the PADI3 promoter. Mutant plasmid screening, gel shift assays, and chromatin
immunoprecipitation indicated the requirement for the activating protein 1 (AP-1) factors c-Jun
and c-Fos bound to PIE1. Chromosome conformation capture analysis revealed increased
physical proximity of PIE1 and the PADI3 promoter in calcium-stimulated as compared with
proliferative keratinocytes in vitro. PIE1 showed no effect in HaCaT cells or carcinoma
keratinocytes, or in fibroblasts. These findings disclose that the interaction of PIE1 with the
promoter region of PADI3 underlies efficient transcription of this gene in differentiating
keratinocytes, through AP-1 factors and probably through the formation of a chromatin loop.
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Comparative genomic hybridization array for Aicardi’s
syndrome: a candidate gene approach
A.-C. Bursztejn1,2, P. Jonveaux1, J.-L. Schmutz2, C. Nemos1. 1Laboratoire de Ge´ne´tique EA4002-
IFR111, 2Department of Dermatology, CHU Nancy, France
We present our methodology for selecting candidate genes in a rare disease, for which the
genetic etiology is unknown. This approach can be used in any medical field including
dermatology. Aicardi’s syndrome is a rare genetic disorder characterized by infantile spasm,
chorioretinal lacunae, and corpus callosum agenesis in females. An X inheritance is strongly
suspected but no genetic cause is yet identified. Here, we hypothesize an autosomic inheritance
with a sex-limited effect and/or a multigenic origin. To verify this hypothesis, we performed DNA
hybridization for DNA from 17 Aicardi patients with a 244K, Agilent CGH array. Patient DNA
was hybridized against a referent DNA pool from healthy females in dye swap. Only variations
observed in dye swap have been considered. We have examined recurrent variations and variable
regions (more than three consecutives probes). False positive of the microarray have been
identified by a self–self hybridization of the DNA reference. The relevance was evaluated on
databases (Database Genomic Variant, DECIPHER, Pubmed). We have established inheritance by
quantitative PCR (qPCR). We have selected only de novo variations. On average, 1,525 variations
have been identified per array, 766 in dye swap. Among these sequences, 57 were recurrent in
more than three patients. We have checked only 14 genes and few non-annotated regions by
qPCR.
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Stroma vascular-derived cells from human subcutaneous
adipose tissue exhibit contractile properties stimulated by NGF
M. Dumas1, C. Viennet2, A.-C. Goydadin2, S. Robin3, A. Zakaroff-Girard4, F. Pellicier1, S.
Schnebert1, M. Lafontan4, J. Galitzky4, J. Franchi1, P. Humbert2. 1LVMH Recherche, Saint-Jean-
de-Braye, France; 2LIBC Inserm U645, IFR133, Besanc¸on, France; 3Bioexigence, Besanc¸on,
France; 4INSERM U858, Institut de Me´decine Mole´culaire de Rangueil, Toulouse, France
Stroma vascular cells surrounding the human subcutaneous mature adipose cells are a source
of multiple mesenchymal lineages. They can express specific adipogenic, osteogenic, and
chondrogenic markers and can differentiate into myogenic and functional cardiomyocyte lineage
and also into neurogenic lineage. For illustrating this plasticity, we previously showed that stroma
vascular-derived cells (SVCs) treated in vitro with transformation growth factor-b were able to
express as fibroblasts do, a-smooth muscle actin, a marker of myofibroblasts. This study
investigates the contractile properties of human SVCs compared with dermal fibroblasts (DFs)
obtained from the same donors, skin locations, and culture conditions. When placed in floating
collagen lattices (8.105 cells/ml in 2 mg ml1 type I collagen), SVC and DF contraction kinetics
(up to 10 days) were identical. When immobilized in the GlaSbox device for a 48-hour
measurement of strengths during isometric dermal remodeling, the SVCs embedded in collagen
lattices exhibit equivalent or higher tensile strengths than DFs. Moreover, 100 ng ml1 nerve
growth factor (NGF) significantly stimulated SVC isometric forces. We conclude that the stroma
vascular is a reservoir of NGF-sensitive fibroblast-like cells able to reorganize and tense the
dermal collagen matrix. This illustrates the SVC plasticity and their possible role in controlling the
biomechanical properties of the dermis.
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Nail wettability in vivo. Effects of ethnicity and treatments
A. Elkhyat, T. Lihoreau, P. Humbert. Research and Studies Center on the Integument (CERT),
Dermatology Department, University Hospital Saint-Jacques, Besanc¸on, France
Hardness of the nail is also based on its affinity with water. A too dry nail becomes breakable
and fissures more easily, and a too wet nail weakens and loses a part of its impermeability,
opening the way to contamination. The main constituent of nail is keratin; nail is also composed
by lipids and minerals. The keratin—which is among the elements that is present in the skin and
hair—is a fibrous material insoluble in water, to ensure impermeability and protection against
external agents. The degree of spreading water on the nail is an indicator of its hydrophobic or
hydrophilic tendency. The objective of this study was to measure the water contact angle of the
nail (water being the reference element of hydrophobic/hydrophilic balance). The effects of
ethnicity, sex, washing, and degreasing are studied. A total of 36 volunteers of four different
countries (China, France, Iran, and Morocco; 21 females and 15 males) participated in this study.
The water contact angle yw is measured by a system developed for in vivo and in vitro
measurements. The surface of the nail is a hydrophilic surface with yw¼ 681. No significant
difference function of ethnicity and sex were observed. The washing with soap and water, and the
degreasing (acetone) increase its hydrophobicity and yw increases 811 and 891, respectively.
Discussion: Today, the nail wetting is very little studied and therefore comparisons of our results
are limited. The value of nail wettability is located between that of the forearm (yw¼ 901) and the
forehead (yw¼ 551). The washing or the degreasing of the nail increases its hydrophobicity;
therefore, it becomes more dry, fragile, and brittle.
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Synthesis and characterization of IgA anti-epidermal
transglutaminase: first step to a murine model of dermatits
herpetiformis
V. Doffoel-Hantz1, M. Cogne´2, A. Sparsa1, C. Be´dane1. 1Department of Dermatology, CHU
Dupuytren, 2Immunology Research Laboratory CNRS 6101 University of Limoges, France
Dermatitis herpetiformis (DH) is a blistering autoimmune disease, associated with
immunoallergic reactions to gluten antigens. Even if epidermal transglutaminase (ETG) has been
implicated as the major autoantigen in DH, the mechanism for deposition of IgA, the exact roles
and consequences of these antibodies remain unclear. Transgenic humanized mice, obtained by
knock in a1-Igs constant fragment gene, have been immunized with recombinant ETG antigens.
Polyclonal antibodies and mAbs have been produced by the classical method of hybridoma
generation. Specificity of the produced monoclonal IgA has been characterized. Splenocytes
obtained from transgenic mice produced only IgA. These chimeric IgAs, with humanized heavy
chains, have been characterized for the specificity of anti-ETG. This specificity could be assessed
by ELISA, direct immunofluorescence on Hacat cells culture, indirect immunofluorescence and
immunochemistry on human skin, and immunoblot on human epidermal proteins extract.
Production of humanized IgA specific for ETG is the first step toward further comprehension of the
pathogenesis of DH. IgA anti-ETGs are necessary but not sufficient to induce the disease. Other
partners of the inflammatory response have to be defined. In this way, using our original produced
reagents, a murine model, is under study. After preliminary purification and concentration of the
chimeric and humanized IgA, they are now used for immunization of NUDE mice. Indeed, lack of
T cells may be a necessary condition to break the tolerance to gluten antigens and lead to DH.
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Parallel clonal microcultures of keratinocytes reveal the
functional hierarchy of the basal layer of human epidermis
N.-O. Fortunel, E. Cadio, P. Vaigot, S. Moratille, M.-T. Martin. CEA, IRCM, Laboratoire de
Ge´nomique et Radiobiologie de la Ke´ratinopoı¨e`se, Evry, France
The basal layer of human interfollicular epidermis is of the highest interest for skin research
as it contains both the stem cell reservoir and the compartment of keratinocyte progenitors.
Because of this heterogeneity of basal keratinocytes, the development of methods suitable for
functional investigations at a clonal level is needed. Here, we describe a new method that allows
multi-parallel clonal cultures of basal keratinocytes. Immediately after extraction from skin, these
basal keratinocytes are sorted by flow cytometry and plated individually in separated
microculture wells. This rapid and self-acting process of cell deposition enables large-scale
parallel characterization of primary clone-forming efficiencies. The resulting clonal growth profile
provided a precise and reproducible assessment of basal keratinocyte functional hierarchy, as the
size distribution of 14-day-old clones ranged from small abortive clones to highly proliferative
clones containing up to 1.7 105 keratinocytes. Importantly, the primary clones could be used to
generate three-dimensional reconstructed epidermis with the progeny of a single basal cell. In
long-term cultures, highly proliferative clones could sustain extensive expansion of more than
120 population doublings. Finally, we show that the method can be used to characterize the
functional consequences of a genotoxic stress on human keratinocyte growth potential. In
summary, parallel clonal microcultures provide an experimental model, which will be
particularly relevant to improve our understanding of the stem and progenitor cell compartments
in the epidermis.
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